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A POLICY FRAMED ANALYSIS OF THE VALLEY OF DEATH IN 
U.S. UNIVERSITY TECHNOLOGY TRANSFER 




At least as far back as the enactment of the Bayh-Dole Act of 1980 there has been 
an ongoing desire on the part of politicians, policy-makers and the public in the U.S., to 
obtain greater economic returns on the federal investment in publicly funded university 
research.  Today among policy-makers there is an apparent belief that a capital shortage 
in the mid-stages of technological development is the rate-limiting factor, preventing the 
maximum flow of university inventive knowledge from entering the marketplace.  The 
consequence is a Valley of Death demise for the vast majority of university inventions.  
In order to mitigate the problem, changes to federal granting policies are placing 
increased emphasis on funding more applied and translational research than basic 
fundamental science.  Given the foregoing direction of policy, the study set out to 
confirm the current understanding of the Valley of Death on the part of policy-makers 
and relate this understanding to the historical evidence. 
Consistent with present-day political pronouncements, the study findings verify 
an overwhelming belief that a shortfall of applied research funding is the root cause of 
the Valley of Death.  Policy-makers believe this shortfall constrains the development of 
basic research into commercializable products.  However, the study also found that this 
perception is inconsistent with the empirical evidence.  The study reveals a gap between 
these sectors but the gap is independent of the stage of technological development.  A 
iii 
funding difference extends the entire length of the research and innovation spectrum, 
suggesting other factors are responsible for the adoption of university inventions, 
bringing into question the direction and likely efficacy of current policy initiatives. 
The findings lend credence to the less cited cause of the Valley of Death, namely 
a Darwinian Sea of survival of the economically fittest technologies (Auerswald & 
Branscomb, 2003).  The actual stage of development of a university invention will 
determine the extent of investment funding necessary for its continued development, but 
economic factors will determine if further investment in its development is warranted.  A 
death does exist for many inventions, but it is the result of natural market causes and not 
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Increasingly, the value of academic research to society is being measured by the 
translation of its results into marketable products and services (Obama, 2011).  Central to 
these translational efforts is the university technology-transfer process, which has been 
the subject of growing academic and public interest in the U.S. since the time of the 
Bayh-Dole Act of 1980 and today remains a focal point of policy attention (Graff, 
Heiman, & Zilberman, 2002).  This interest is no better exemplified than when the White 
House issued a request for information (RFI) to identify ways to increase the economic 
impact of the federal investment in university research (RFI, 2010).  The White House 
requested information on current best practices in the field and sought suggestions to help 
expedite the movement of technologies out of the laboratory and into the market.  
Evidence to date indicates the vast majority of university inventions fail to achieve 
economic success, and this phenomenon has been dubbed the Valley of Death 
(Auerswald & Branscomb, 2003).  This metaphorical valley represents the graveyard for 
new technologies where they perish in an attempt to move along their development 
pathway from an initial idea to the end-market in the form of new products, processes, 
and services.   
The White House RFI was an initiative to gather input on the issues of the Valley 
of Death and to develop a consensus strategy to mitigate its effects.  It is generally 
accepted in the public policy literature that perceptions and coalitions of shared beliefs 
form the impetus of policy-making (Sabatier, 1991; Shanahan, Jones, & McBeth, 2011).  
As such, the RFI provided a mechanism to crystallize shared beliefs and to help form a 




the literature reveals little published empirical work to lend credence to any anecdotal 
evidence, which could be proffered from the responses to the RFI.  To help support the 
attainment of national goals for the effective translation and market adoption of 
university inventions, further research is needed on the nature and cause(s) of the Valley 
of Death.  Contribution to these aims underpinned the motivation for the study.   
Background 
President Obama’s Administration’s attention to the economic potential of 
academic research is most laudable.  However, recognition of the importance of basic 
scientific research and its role as a driver of technology-based economic development in 
the U.S. is not new, neither is the desire for politicians and policymakers to seek ways to 
enhance its effectiveness (cf.  Abramovitz, 1956; Arrow, 1962b; Bush, 1945).  A deeper 
recognition of the merits of basic scientific research to society began to emerge in the 
United States toward the end of the Second World War.  Vannevar Bush, Director of the 
Office of Scientific Research and Development at the time, presented a report to the 
President on a program for postwar scientific research (Bush, 1945).  As a prefacing 
comment to the published report, President Roosevelt remarked “the Office of Scientific 
Research and Development represents a unique experiment of team-work and 
cooperation in coordinating scientific research and applying existing scientific knowledge 
to the solution of the technical problems paramount in war” (Bush, 1945, p. vii).  
Roosevelt further speculated that the structure employed and the lessons learned could be 
effectively utilized in times of peace, and toward that end, he expressed the following:  
The information, the techniques and the research experience developed by the 
thousands of scientists in the universities and in private industry, should be used 




of new enterprises bringing new jobs, and the betterment of the national standard 
of living.  (taken from the copy of a letter from President Roosevelt, reproduced 
in the preface to Bush, 1945, p. vii) 
The net result of Roosevelt’s belief was the development of a national policy position on 
the utilization of scientific knowledge for the public good, and that principle has formed 
an essential component of U.S. administrative and economic policy for almost seventy 
years. 
Concurrent with the policy position espoused by Roosevelt, the economic 
thought-leaders of the day were re-formulating classical and neo-classical economic 
theory.  Innovation, over and above labor and capital, was becoming recognized as the 
primary impetus of economic growth (cf. Arrow, 1962b; Bush, 1945; Schumpeter, 1939; 
Solow, 1956).  Consequently, the U.S. policymaking principles of fostering basic science 
as a potential driver of innovation and economic development directly paralleled 
emerging academic thinking.  Formal federal commitment to the application of science 
from that time has been evidenced by such follow-on measures as the creation of the 
National Science Foundation in 1950, the passage of the Bayh-Dole Act in 1980, the 
Small Business Innovation Act 1982, the National Cooperative Research Act of 1984, the 
Technology Transfer Act of 1986, the Advanced Technology Program under the 
Omnibus Trade and Competitiveness Act of 1988, the Technology Innovation Program 
under the America Competes Act of 2007, and has most recently revised patent 
legislation under the America Invents Act of 2011.  
Within the public policy realm of university technology transfer, the Bayh-Dole 
Act of 1980 has been touted as having a key influence on the rate of growth of 




motivation for the recent White House RFI, the original purpose of the Bayh-Dole Act 
was to address a perceived failure in the transfer of public sector research results to the 
private sector.  Unlike today where the failure to translate research results is now 
believed to stem from an applied research funding shortfall, in 1980 the consensus belief 
for the failure was a lack of granting agency consistency with respect to ownership and 
transferability of intellectual property rights ("Bayh-Dole," 1980).  The resulting 
legislation vested universities with ownership rights to inventions emanating from federal 
research funding, plus the ability to license those rights to industry. 
By many accounts the Bayh-Dole Act has been considered a success and as stated 
in the Congressional Research Service’s recent report to Congress, “the Bayh-Dole Act 
appears to have met its expressed goals of using the patent system to promote the 
utilization of inventions arising from federally-supported research ... and to promote 
collaboration between commercial concerns and nonprofit organizations, including 
universities” (Schacht, 2012, p. 8).  In one of the earliest reviews of the legislation, the 
General Accounting Office found agreement among university administrators and small 
business representatives, stating that the Bayh-Dole Act had “a significant impact on their 
research and innovation efforts” (U.S. General Accounting Office, 1987, p. 3).  The 
Association of University Technology Managers (AUTM), the professional body for 
universities and other research-related organizations engaged in technology transfer, also 
cites “one need only review the data we’ve gathered over the past twenty years to know 
that the Bayh-Dole Act is working.  Innovative technologies no longer sit in university 
labs benefiting no one” (AUTM, 2010, p. 3).  The organization boasts that, as a result of 
university innovations, products that benefit the public enter the market every day and 




economies” (AUTM, 2010, p. 3).  In addition, AUTM notes 38,473 active technology 
licenses exist between its members and industry, producing approximately $2 billion 
annually in licensing revenue for universities (AUTM, 2011). 
What both AUTM and the noted reports to Congress fail to highlight is the 
approximate 300,000 invention disclosures received by TTOs since the enactment of 
Bayh-Dole that have failed to make it to market (AUTM, 2011).  Utilizing AUTM’s 
numbers represents a potential multiplier effect of approximately 9 times what has been 
commercialized to date, or an estimated $18 billion annually in additional royalty income 
to universities.  Since universities only receive royalty licensing income as a small 
percentage of the final product sales by a licensee company, averaging 3% (Stevens & 
Phil, 2003), the potential economic opportunity cost of the failure of inventions to be 
commercialized translates to $600 billion annually. 
The foregoing estimate of the potential economic scale of the issue not only 
provides a logical rationale for the level of public interest but also underscores the 
concern that the commercialization process should be as effective as possible.  This 
concern is evidenced not only by the previously mentioned RFI, but also by calls from 
other engaged parties such as the Kauffman Foundation.  They have argued “although 
there is general consensus … that the Act [Bayh-Dole] has accelerated the 
commercialization of university-developed inventions … there is reason for believing 
that the pace and amount of commercialization is sub-optimal” (Litan & Mitchell, 2009, 
p. 1).  The calls for improvement immediately prompt additional questions, not the least 
of which is to increase the emphasis of academic R&D as a strategic vehicle for 
economic development rather than economic development being a by-product of 




fundamental shift in academic purpose that many academicians question and fear (Lee, 
1996).  
From a political standpoint, the 2012 presidential race between Obama and 
Romney served to provide recent insight into current perceptions on the matter of 
university research commercialization.  On the one hand, Obama stated he would seek to 
increase the federal commitment for basic research, which is consistent with his 
previously stated  positions, including the time when he noted in a National Academy 
speech, “it was basic research … that would one day lead to solar panels … the CAT scan 
… GPS satellites” (Obama, 2009, p. 4).  Contrastingly, Romney recognized the value of 
basic research but would have focused federal research policy on developmental 
programs (versus basic research) to form a platform for future private sector 
commercialization (Obama & Romney, 2012).  Romney did not suggest how new 
underlying basic research would emerge as a feeder for follow-on development.  In this 
regard, Obama’s position appears more nuanced than Romney’s does, given Obama 
follows accepted academic thinking and provides an acknowledgement of the 
understanding that basic research forms a foundation for invention, which is an input for 
economic innovation (Maclaurin, 1953).  Despite differences in political positions, a 
common underlying belief was demonstrated by both politicians, namely a need to 
enhance the technology transfer process.  
Prima facie academic evidence for the belief that the research currently taking 
place on U.S. university campuses may lay the foundation for future economic growth 
and societal well-being is further demonstrated by the peer-reviewed journal, Economic 
Development Quarterly.  This journal focused its entire February 2013 edition to the 




potential of basic university research is also captured in the following statements 
contained in the Federal Register, “The Federal government supports university-based 
research for a variety of reasons.  Expanding the frontiers of human knowledge is a 
worthy objective in its own right.  Basic research that is not motivated by any particular 
application can have a transformative impact” (RFI, 2010, p. 14476).  However, at the 
opposite end of this ideological position is the reality politicians and policymakers face, 
namely the accountability associated with spending taxpayers’ dollars.  This dilemma is 
evidenced by an ensuing statement contained in the same RFI cited above, “The 
Administration is interested in working with all stakeholders (including universities, 
companies, federal research labs, entrepreneurs, investors, and non-profits) to identify 
ways in which we can increase the economic impact of federal investment in university 
R&D” (RFI, 2010, p. 14476).  In a similar vein, recent academic attention has focused on 
the efficiency and effectiveness of transferring the results of publicly funded basic 
research to the private sector (cf. Graff et al., 2002; Litan & Mitchell, 2009; Niosi, 
Treurnicht, & Samarasekera, 2008).  The dichotomy between the level of federal 
investment in R&D activity and the perceived economic returns frames the current 
political and policy environment surrounding university technology transfer.  
A desire exists to utilize university technology transfer as an embedded and 
fundamental element of an innovation-driven, national economic development strategy 
(Obama & Romney, 2012; RFI, 2010).  The current mechanisms of university technology 
transfer have predominately grown from patenting and licensing activity being 
undertaken as a specific consequence of the Bayh-Dole Act and have become an 
embedded component of American university infrastructure (Graff et al., 2002; Mowery 




of research results, the most efficient and/or effective structure for that process remains a 
question (RFI, 2010).  Given the indication of the extent of potential economic benefit 
available should more inventions be able to complete the process of commercialization 
(Economic Development Quarterly, February 2013), a full comprehension of this issue is 
warranted.  Deeper understanding, in turn, will yield appropriate, fact-based models to 
lend credence to the belief systems to guide the policy process (Sabatier & Jenkins-
Smith, 1993).  In the pages that follow, including the conceptual and theoretical 
frameworks in this chapter and the literature review in Chapter II, additional perspective 
has been provided on university technology transfer and the Valley of Death, which are 
framed within the U.S. federal policy context. 
Conceptual and Theoretical Underpinnings to the Study 
To better understand the technology transfer environment and the positioning of 
university commercialization activity relative to academic research and industrial 
innovation, a conceptual framework outlining this interaction is provided in Figure 1.  
The conceptual framework locates federal R&D grant funding as input into the 
production of new knowledge.  The subsequent dissemination and adoption of this new 
knowledge yields societal returns in such forms as improved education, health and 
welfare, etc.  The theoretical basis underpinning this component of the conceptual 
framework is founded in human capital development theory, the essence of which is the 
creation, dissemination, and application of knowledge for individual, organizational, and 






Figure 1. Conceptual framework for the generation and dissemination of academic 
knowledge and how policy on the granting process are shaped from perceptions and 
beliefs surrounding the outcomes. 
 
From time to time, outputs of the university, knowledge production-function may 
take the specialized form of an invention.  Knowledge in the form of inventions becomes 
input to the university, technology transfer process, which falls under the purview and 
management of university technology-transfer offices (TTOs).  The flow of inventive 
knowledge reaches TTOs in the form of invention disclosures from the institution’s 
researchers.  Essentially, the TTOs endeavor to have inventions incorporated into the 
industrial innovation process through contractual arrangements with the private sector to 
produce mutual economic benefit (Graff et al., 2002).  Transfers to the private sector 




technology based economic development.  Current understanding of the impact of this 
component of the conceptual framework and the secondary knowledge flow it generates 
has its foundation in the precepts of endogenous economic growth and economic 
development theory (cf. Aghion, Howitt, & García-Peñalosa, 1998; Arrow, 1962a, 1970; 
Brzustowski, 2006; David, 1975; Denison, 1962; Duesenberry, 1956; Freeman, 1990; 
Romer, 1994; Schmookler, 1966; Schumpeter, 1939).  For the reader unfamiliar with 
university technology transfer operating procedures, Appendix A provides a detailed 
description of the technology transfer process and the historical performance measures 
associated with TTOs. 
Unfortunately, not all of the knowledge emanating from TTOs finds its way to 
market, and the great majority of university inventions fail to be commercialized, ending 
up in the Valley of Death prior to reaching industry (AUTM, 2011; Ford, Koutsky, & 
Spiwak, 2007).  Today, the apparent consensus of thought among politicians, academics, 
and policy-makers is that an applied-research funding shortfall constrains basic university 
research from translating into further commercial development (cf. Auerswald & 
Branscomb, 2003; Frank et al., 1996; H.R. Rep. No. 105-B, 1998; Katehi, 2010; 
Markham, 2002; Moran, 2007; Murphy & Edwards, 2003, Wessner 2005; Williams, 
2004; Wylie, 2011).  The foundation for this prevailing belief is drawn from the notion 
that the focus of university research is primarily conducted at the basic end of the 
research spectrum, whereas industry’s research focus is at the developmental end.  A 
funding gap in the middle stage (i.e., applied research) creates a disconnection, which is 
manifested as the Valley of Death.  
From the conceptual framework in Figure 1, both the positive outcomes (Societal 




enterprise create perceptions and beliefs surrounding the effectiveness of the process in 
the minds of politicians, policy-makers and the public.  Importantly, perceptions and 
beliefs frame the design and implementation of public policy (Sabatier, 1991; Sabatier & 
Jenkins-Smith, 1993; Sabatier & Weible, 2007).  As a growing body of empirical 
literature has demonstrated (cf. Bedsworth, Lowenthal, & Kastenberg, 2004; Bridgman & 
Barry, 2002; McBeth, Shanahan, Hathaway, Tigert, & Sampson, 2010), policy narratives 
are the key mechanism for influencing the perceptions and beliefs that eventually direct 
policy-making.  Governing policies need to be congruent with the desired outcomes in 
order to achieve objectives; therefore, the perceptions and beliefs surrounding the Valley 
of Death need to be fully informed to effectively direct policy and address the Valley’s 
root cause.   
Statement of the Problem 
In an attempt to respond to calls for greater economic returns and to mitigate the 
Valley of Death phenomenon, politicians, policymakers, and program directors for the 
U.S. national research granting councils are implementing strategic changes to federal 
grant programming.  Changes are reflected in such initiatives as iEdison, which was 
introduced to track patenting and commercialization activity associated with inventions 
resulting from federal research grants (NIH, 2013a).  In addition, an amendment to NSF’s 
grant terms and conditions requires universities to publicly report their transfer of 
technology and the commercialization of research results emanating from NSF grants 
(NSF, 2013c).  Furthermore, both the NIH and the NSF granting councils have amended 
their application forms to include specific references to potential patentability and a 
principal investigator’s history of patent citations (NSF, 2013d).  From a more political 




Technology Committee, drafted a bill that according to ScienceInsider, “in effect, would 
replace peer review at … NSF with a set of funding criteria chosen by Congress … it 
would also set in motion a process to determine whether the same criteria should be 
adopted by every other federal science agency” (Mervis, 2013, para. 1).  The proposed 
congressional criteria, among other things, would require the research to advance national 
prosperity.  The use of such criteria is an overt move to place funding priority on research 
that holds the potential for more economically driven outcomes over ‘disinterested’ 
fundamental scientific research.  A political and philosophical change is emerging from 
previous policy positions, whereby it has been stated that “many government managers, 
especially those in the core funding agencies, are as concerned about building up 
scientific and technical capacity as much as producing discrete impacts from particular 
projects” (Bozeman, 2000, p. 649).  Shifts in policy of this nature can hold broader 
significance in the realm of human capital development, since too great an emphasis on 
the applied or developmental aspect of academic research and its commercialization 
might actually slow down the social rate of innovation (Feller, 1990). 
Notwithstanding the current moves by politicians and policymakers, studies thus 
far on the Valley of Death have only provided figurative representations of this 
phenomenon, with little empirical basis.  Based on the literature review, no confirming 
evidence isolating the actual historical location of the Valley of Death along the R&D 
spectrum has been identified (i.e., the applied research phase), nor has any attempt been 
made to quantify the amount of the perceived funding shortfall.  Since no fact-based 
work has been observed, it is unclear to what extent the policy changes targeting the 
Valley of Death are necessary, or beneficial, and if they are focused at the appropriate 




efforts, but changes may also result in the unintended consequence of affecting the rate of 
broader human capital growth and societal innovation. 
In summary, a problem exists in that the commercial application of university 
research is considered sub-optimal and, as a result, changes in grant funding criteria are 
being implemented to ameliorate the situation.  However, to confound the issue, policy 
changes are being initiated based on limited empirical evidence.  While the ultimate 
effect is yet unknown, the direction of this particular change has been previously 
hypothesized to hold broader negative societal implications (Feller, 1990).  Given the 
potential impact of proposed policy changes, both positive and negative, an accurate 
assessment of the basis of the Valley of Death phenomenon needs to be ascertained. 
Purpose of the Study 
Knowing the current policy direction and the lack of underlying empirical 
foundation for any proposed changes, the purpose of the study is to develop data that 
would help inform policy-makers on the phenomenon of the Valley of Death.  This was 
accomplished by first confirming the current perception and shared beliefs held among 
policy-makers with respect to the perceived cause of the Valley of Death.  Secondly, was 
the development of a more accurate account of the Valley of Death based on the 
historical record.  A comparison of the data generated provides the consistency of 
presently shared beliefs with historical evidence.  More specifically the research 
objectives were structured as follows: 
Research Objective 1 – determine the frequency of use of the term Valley of 




Research Objective 2 – determine the frequency of use and the referenced 
position of the term ‘funding shortfall’ when policy-makers describe the Valley of Death 
in innovation and technology development; 
Research Objective 3 – determine the pattern of use over time by policy-makers 
of the term Valley of Death in the context of innovation and technology development; 
Research Objective 4 – determine the historical research spending patterns by 
category of research for the university and industrial sectors. 
Limitations 
With respect to research objectives 1, 2, and 3, Titscher, Meyer, Wodak, and 
Vetter (2000) suggest content analysis be used when the communicative content is of 
greatest importance.  In performing content analysis on a text, the data must be subject to 
strict categorical definitions and procedures and not demonstrate any observer 
dependency (Krippendorff, 2012).  The key limitation of this method is that it simply 
describes what is there, but may not reveal the underlying motives for the observed 
pattern, that is, the 'what' but not the 'why' (Titscher et al., 2000).  Content analysis is also 
limited by the use of relevant material, which in this case will be contained to the 
Congressional Record.  As a formal public record, the method of speech and delivery of 
the message by the speaker may be influenced and thereby potentially skew the content 
(Krippendorff, 2012).   
In order to determine the construct of the Valley of Death (Research Objective 4), 
data was sourced from the historical record contained in the NSF’s database of National 
Patterns of R&D Resources (NSF, 2011).  To the extent that these records were 
incomplete, contained errors, or had altered their collection methodology and/or 




addition, the NSF’s classification of R&D spending data under the terms of basic, applied 
and developmental research formed the structure of the database and therefore limited the 
presentation of the Valley of Death phenomenon.  The lack of more detailed data is the 
key point made by Godin (2006) with respect to describing the overall nature and 
limitations on the use of the linear model of innovation, which itself forms a key 
assumption of this study.  The foregoing limitations lead to potential construct validity as 
well as potential threats to external validity.  These threats are further discussed in 
Chapter V. 
Delimitations 
Delimitations are those characteristics selected by a researcher to define the 
boundaries of a study.  One key delimiting factor of the study was the use of the 
Congressional Record as the source of information for policy narratives related to the 
meaning and perception of the Valley of Death.  Use of wider textual sources could 
provide richer meaning to the term; however, focus on the Congressional Record ensured 
the sources of the information and the targeted listening audiences were direct influencers 
on the policy process.  
A second delimiting factor was the confinement of the study to U.S. university 
research funded from federal sources.  In its broadest sense, the Valley of Death covers 
the development of all research-based technologies.  Given that almost 30% of the U.S. 
annual federal research budget goes to universities and colleges and as this sector has 
represented the largest single sector for federal R&D spending since 2002 (NSF, 2011), 
U.S. universities and colleges formed the primary and logical focus for the study on the 
Valley of Death consequence of technology transfer.  However, as a result non-U.S. 




these other areas include State or foundation funded research, federal labs, research 
hospitals, government agencies, and federally funded (private sector managed) proof of 
concept centers.  Additionally, attention was solely on university-generated inventions 
and not those inventions created within industry, which could also receive federal 
funding support (i.e., Small Business Investment Research grants) and which may too, 
fail to reach market.  Restrictions on the interpretation of the findings caused by the 
delimitations of the study are more fully addressed in the discussion of the results in 
Chapter V.  
Assumptions 
There are two main assumptions associated with the research objectives of the 
study.  First, Advocacy Coalition Framework (ACF) and Narrative Policy Framework 
(NPF) are considered to form the underlying structure to the general policy-making 
process, but the application of these frameworks to the issue of technology transfer and 
the commercialization of university research has not yet been examined.  The process 
surrounding federal research grant policy was assumed to be consistent with the other 
federal policy-making processes, which have formed the precepts for these frameworks 
and hence, the applicability of these models to the study.   
A second assumption underpinning the study is the use of the linear model of 
innovation to provide the theoretical structure that governs the relationship among basic, 
applied, and developmental research.  This model holds that these three categories of 
research are sequential and together form a developmental continuum from lab to market 
(Godin, 2006).  The linear model of innovation frames the graphical plane (i.e., the x-






The conceptual and theoretical precepts related to university technology transfer 
demonstrate how innovation emerges from the inventive process and how inventions are 
derived from the development of new knowledge.  The relationship of knowledge and 
invention to end-market products or services are juxtaposed at opposite ends of an 
innovation process spectrum (reflective of the linear model of innovation).  Such 
juxtaposition sets up the potential for discontinuity (i.e., Valley of Death) along this 
innovation continuum, especially if various actors are operating at different points within 
this spectrum. 
In an age of increasing global competition, the ability to innovate is seen as the 
basis for continued economic growth (Friedman, 2007; Romer, 1994).  Innovative 
capability is the capacity to generate and apply new knowledge and is a function of the 
level of human capital development achieved (Mincer, 1984).  In the United States, a 
substantial amount of federal dollars is expended on university R&D to expand the 
human capital base and create new knowledge (NSF, 2011), providing the potential for 
enhanced economic competitiveness and growth.  However, much of the inventive 
activity emerging from university labs is lost along the development pathway to market 
and ends up in a proverbial Valley of Death (Ford et al., 2007).  The consensus belief 
cited for this failure is a lack of funding in the applied research stage of development 
(Beard, Ford, Koutsky, & Spiwak, 2009).  In response, federal policy is evolving and 
since policy-making is a function of shared beliefs and perceptions (Sabatier, 1991), the 
first objective of this study confirmed the current meaning and common use of the term 




based model of the Valley of Death, demonstrating how the current perception/belief 
aligns with the historical evidence.  
The remaining chapters of this study include a review of the relevant literature, a 
detailed explanation of the research methods employed, the results, and a discussion of 
the findings.  The study closes with recommendations for additional research, with 







The argument has been presented that the theoretical framework for this study can 
be described as an interdisciplinary examination residing at the intersection of human 
capital development theory and endogenous growth theory.  The generation, 
dissemination, and application of new knowledge in the form of inventions,  a human 
capital development matter (cf. Becker, 1964, 2002; Kern, 2009; Leslie & Brinkman, 
1988; Mincer, 1984), creates a foundational input to innovation driven economic 
development, an endogenous growth matter (cf. Aghion et al., 1998; Arrow, 1962b, 1970; 
Freeman, 1990; Romer, 1994; Schmookler, 1966; Schumpeter, 1939).  From this 
perspective, the failure to commercialize university inventions essentially reflects the 
direct consequence of the market not fully adopting all new knowledge emanating from 
TTOs.  An applied research-funding shortfall is attributed as the cause of the problem, 
and current federal policy direction is shifting the focus of available grant funding in an 
attempt to address the issue (Ford et al., 2007).  This literature review is structured to 
focus on the foregoing interrelationships and circumstances and will follow the logical 
flow of the conceptual framework depicted in Figure 1 herein. 
The literature on the interrelationship between human capital development and 
endogenous economic growth leads to the industrial innovation process, which is 
specifically manifested in the linear model of innovation (Godin, 2006).  The linear 
model forms the underlying pathway for the commercialization of new inventions, and an 
investigation of its principles reveals how inventions translate into the final products and 




university in this process is reviewed to provide perspective for the basis of the current 
practice of university technology transfer.  The substance of this prefacing examination 
establishes an overall perspective for the circumstances surrounding the Valley of Death, 
which then forms a specific section of the literature review.  The Valley of Death 
component addresses the extent of the current comprehension of this phenomenon, 
including how it has been defined as well as its currently known delimiting parameters.  
The recognition of the existence of the Valley of Death in relation to the accepted role of 
the federal government in R&D and technology transfer is explored in the final section of 
the literature review.  This approach to the literature review provides a full and 
appropriate foundation for the research objectives of the study.  
Human Capital, Invention, and Industrial Innovation 
Most of the literature and growth in understanding the relationship of innovation 
to the economy originated from the founding works of the renowned economist, 
Schumpeter (1939).  As summarized by Nelson “virtually all contemporary general 
accounts of the capitalist engine are based on Schumpeter” (Nelson, 1990, p. 193).  One 
early study that led directly from Schumpeter’s initial principles on innovation was 
conducted by the historian and economist, Maclaurin (1953).  He analyzed the sequence 
from invention – to innovation – to economic growth.  Within his work, he laid the 
framework that related: (1) the propensity to develop pure science; (2) the propensity to 
invent; (3) the propensity to innovate; (4) the propensity to finance innovation and; (5) 
the propensity to accept innovation (Maclaurin, 1953).  Maclaurin’s chain of events 
demonstrated an evolution in the understanding associated with the overall process of 
innovation and important to universities, he added the elements of pure science into the 




provides a natural starting point for the industrial innovation process (Godin, 2006) and 
the industrial innovation process is commonly referenced alongside the concept of ‘the 
linear model of innovation’.  According to Godin (2006), the linear model contends that 
innovation starts with basic research, moves through applied research, then development, 
and ends with production and diffusion in the marketplace. 
The exact origin of the linear model does not appear to have ever been 
documented (Godin, 2006).  Instead, the model appears to have been generally taken for 
granted, but according to many, it initiated from Bush’s work, Science: The Endless 
Frontier (for examples of this attribution refer to: Freeman, 1996; Hounshell, 1996; 
Irvine & Martin, 1984; Mirowski & Sent, 2002; Mowery, 1997; Stokes, 1997).  However, 
Bush like Schumpeter, only discussed linkages between science (i.e., basic research) and 
socioeconomic progress.  They did not provide details on the mechanism whereby 
science translates into either social or economic benefit through some sequential linear or 
other linked process (Godin, 2006).   
Godin traced the history of the model and concluded that it developed in various 
overlapping stages.  He argues that the linear model of innovation was not a spontaneous 
invention arising from the mind of one individual, that is to say Vannevar Bush; instead, 
it evolved over time in three notable phases: 
1. The first phase was during the period from the beginning of the twentieth 
century to the end of the Second World War (i.e., during the times of Bush and 
Schumpeter), and it was predominately concerned with the first two terms in the model 
namely, basic and applied research.  This period was characterized by the ideals of pure 




2.  The second phase lasted from 1934 to 1960 and added a third term to the 
equation, namely development.  This created the standard three-stage model of 
innovation: Basic research → Applied research → Developmental Research.  Analytical 
as well as statistical gathering methodologies were cited as being responsible for driving 
this period of evolution of the model.  
3.  The third phase, starting in the 1950s extended the development end of the 
model to non–R&D activities of production and diffusion as is exemplified the work of 
Maclaurin (1953).   
Godin demonstrated how the evolution of the linear model of innovation also 
reflected the successive entry of three separate academic disciplines into the field.  First 
were natural scientists (academic and industrial); they espoused that basic research is the 
source for applied research and technology.  Second were researchers from business 
schools; they studied the industrial management of research and the development of 
technology.  Third were the economists; they advanced the understanding of innovation 
and the economy.  The three groups of academicians, with their differing perspectives, 
were advocating on three different fronts, respectively: (a) public support for basic 
university research; (b) the importance of technological development to the firm and; (c) 
the impact of research on economic growth and societal benefit. 
The linear model of innovation has survived despite criticisms of its simplicity 
such as “the linear model is insufficient as a descriptor of the industrial innovation 
process.  Everyone knows that the linear model of innovation is dead ... It was a model 
that, however flattering it may have been to the scientist and the academic, was 




just being dead, it has been postulated by Edgerton who states, “it [the linear model of 
innovation] never existed” (Edgerton, 2004, p. 8).   
According to Godin, the model’s longevity is fundamentally rooted in the use of 
available statistics.  By collecting official data on research as defined by three key 
components (i.e., basic, applied, developmental), presenting, and discussing one after the 
other within a sequential framework the federal government has crystallized the model.  
The survival of the linear model indicates both how the use of statistics supports concepts 
and how their absence limits adoption of other analytical models.  Godin (2006) states  
“rival models, because of their lack of statistical foundations, could not become 
substitutes easily” (p. 641).  Refinements to the linear model, which may be fully 
justified and advocated by Rosenberg and Edgerton, will not occur until refinements to 
the data are obtained. 
Invention, the Basis of Innovation   
As noted above, the linear model of innovation initiates with new knowledge and 
invention (Godin, 2006; Maclaurin, 1953), but the question of how and why invention 
takes place remained a question.  This was separately studied by Usher, whose findings 
led to definition of invention as the emergence of new things, which require an act of 
insight going beyond the normal exercise of technical or professional skill (Usher, 1954).  
Additional work within the field suggests that required acts of insight can be precipitated 
by social needs (Bijker, 1995), they respond to economic opportunities, perceived risk, 
and factor price changes (David, 1975; Dosi, 1998; Freeman, 1990; Rosenberg, 1982), 
they emerge from the accretion of both cultural and scientific knowledge (Mokyr, 2002), 
and they can be catalyzed by the exchange of information within networks of colleagues 




What distills from the foregoing collage of scholars is the commonality that 
novelty and inventiveness stem from increased awareness and a growing knowledge base.  
The standard academic modus operandi of constantly researching to add to the body of 
knowledge therefore forms an ideal foundation for inventiveness.  The role of U.S. 
universities’ contribution to the process of innovation is reviewed in the following 
section.  
U.S. Universities and Technology Transfer 
The American land-grant university system emerged with distinctive structural 
characteristics that differentiated them from their European counterparts (Kerr, 1963).  
The Morrill Act of 1862 was founded on the commitment that American universities 
should serve their citizens (Kerr, 1963).  Under the Morrill Act, the purpose of education 
shifted away from classical studies to more applied studies to prepare students for roles 
after graduation (Kerr, 1963).  As a result, universities in the United States have been 
making positive contributions to the nation’s economic and social wellbeing throughout 
their history (Mowery et al., 2004). 
Major research universities generate a huge economic footprint (Lugar & 
Goldstein, 1997).  In many locales, universities are the largest employer, and several have 
total expenditures that put them at the level of some of the largest corporations in the 
nation.  However, as important as this economic activity may be from a regional 
development standpoint, it is recognized that a greater contribution stems from the 
university’s basic mission of generating and disseminating knowledge (Leslie & 
Brinkman, 1988; Mansfield, 1991).  As noted in Chapter I, many groups are seeking to 
utilize university expertise in a more expeditious fashion for greater and immediate 




application and commercial exploitation of university intellectual property for economic 
growth through the process of technology transfer. 
Although American universities have been committed to technology transfer since 
inception (Mowery et al., 2004), the post-war era has witnessed the occurrence of three 
distinct modern evolutionary phases of technology transfer (Geiger, 1992, 2004; Godin, 
2006).  The first phase of technology transfer evolution occurred between universities 
and the defense establishment.  Academic scientists were financially supported to 
conduct research, develop and maintain expertise in key areas, and ultimately to produce 
solutions that were demanded by the military.  These tasks were accomplished through 
directed processes rather than market relationships.  Although close relationships 
sometimes developed between supporting agencies, university scientists, and the 
companies that manufactured the final products, markets played virtually no part in 
coordinating the university’s role (Geiger, 1992, 2004). 
The second major phase of modern university technology transfer evolution grew 
from advances in medical research and similar to the first phase, the federal government 
was also the patron, specifically the NIH (Geiger, 1992, 2004).  The ultimate objective of 
the NIH’s substantial investment in basic biomedical research was to cure disease and 
improve the human health condition.  Prior to 1980, this activity largely involved non-
market relationships among government, industry, and academe.  Any interaction with 
universities primarily focused in clinical research, which concerned diagnosis, 
identification of therapeutic targets, and refinements of treatment, not the invention of 
products.  From a market perspective, medical and pharmaceutical firms typically looked 




The third aspect of the modern technology transfer evolution has moved 
universities in a fundamental way into the marketplace and has occurred predominately 
since 1980 (i.e., the time of the Bayh-Dole Act).  This phase has been dubbed “civilian 
technology transfer” by Geiger (1992, p. 9).  Because of civilian technology transfer, 
both the purpose and modus operandi is now quite different.  Universities actively seek to 
sell research services to industry, market intellectual property, and launch and nurture 
new companies, sometimes with their own venture capital funds (Geiger, 2004).  Tassey 
(2001) further describes the change in the fundamental character of the products and 
services being developed for civilian technology transfer.  He notes a movement from 
public to private goods over the course of a technology’s development, and the end 
product reflects a combination of both public and private goods.  Tassey observed that 
while “basic science is widely recognized as close to a pure public good … technology is 
a mixed good, containing both private and public elements” (Tassey, 2001, p. 37).  
Moreover, the public/private mix adjusts as technologies become more developed.  The 
slow development into a viable product is a process of creating private value but they 
contain public resources as their foundation.  The argument behind the public support of 
private gain from public dollars is derived from the notion that broader public benefit will 
eventually accrue in terms of present and future economic spin-off activity (Tassey, 
2008). 
Today the research and technology development enterprise has merged activities 
that previously occupied opposite ends of the development spectrum and involved 
different actors (Mowery et al., 2004).  A result has been a stimulation of investment in 
certain areas of university basic science and engineering; however, the economic 




commercialization of that science (Tassey, 2001).  The new reality for universities is that 
these endeavors are no longer differentiated components at opposite ends of the 
spectrum, but part of a complex, unified endeavor.  A philosophical dichotomy arises 
given the private nature of the end-products versus the public source of funding used to 
develop those products (Tassey, 2001, 2008).  This suggests that the mission of U.S. 
universities to provide public service via public goods (Kerr, 1963) has morphed.  In the 
original model, no one was precluded from using the knowledge at hand.  In the current 
model, private property rights emerge; there is an operational focus on the generation and 
transfer of public goods for the benefit of private actors (Tassey, 2008).  This is 
manifested by the emergence of university TTOs seeking and licensing patent rights, 
mostly on an exclusive basis (Mowery et al., 2004). 
Modern Patterns of Technology Transfer 
According to Abramson, Encarnacao, Reid and Schnmoch, “the principal 
contribution of universities to the technical needs of industry is human capital, consisting 
of well-educated, skilled graduates” (Abramson, Encarnacao, Reid, & Schnmoch, 1997, 
p. 11).  This quote emerged from a bi-national panel on technology transfer systems in 
the United States and Germany.  The bi-national panel also distinguished between direct 
and indirect forms of technology transfer by noting  “direct technology transfer is linked 
to specific technologies or ideas and to more visible channels such as contract or 
cooperative research projects … indirect technology transfer concerns the exchange of 
knowledge through such channels as informal meetings, publications or workshops” 
(Abramson et al., 1997, p. 3).   
The relative importance of the various forms of technology transfer and the 




mentioned above, was examined by Cohen, Nelson, and Walsh (2002).  They surveyed 
managers of R&D units of manufacturers located in the U.S.  The survey sample was 
randomly drawn from private labs listed in public directories and entailed a sample size 
of 3,240 labs.  The authors received 1,478 responses, yielding a gross response rate of 
46%.  Among the questions posed, the authors asked industry to what extent they relied 
on various forms of information exchange with universities.  Their results have been 
summarized in Table 1.   
Table 1 
Relative Importance of Source Mechanism of Technology Transfer to Industry 
Source Mechanism 
Percentage of survey respondents rating source as 
“moderately” or “very important” 
  
Publications and reports 41.2 
Informal interaction 35.6 
Meetings and conferences 35.1 
Consulting 31.8 
Contract research 20.9 
Recent hires 19.6 
Cooperative R&D 17.9 
Patents 17.5 
Licenses 9.5 
Personnel exchange 5.8 
  
 
Source: Adapted from Cohen et al. (2002). 
 
As revealed in Table 1, the relative positioning of patents and licensing (i.e., 
direct technology transfer) as industry’s source of new knowledge was eighth and ninth 
in a list of ten.  The patents and licenses categories reflect the mechanism of technology 
transfer employed by university TTOs and are a direct representation of ‘inventions’ in 




Cohen et al.’s (2002) findings reveal a direct contradiction to the basic arguments 
of policy makers and other original proponents of the Bayh-Dole Act.  The Bayh-Dole 
legislation had been advocated based on the position that technology transfer was failing 
due to weaknesses in intellectual property rights and in order to create more effective 
transfer and application of university research; specific ownership control and 
mechanisms for the transfer of patenting rights were required.  The policy-makers 
position is specifically captured in the preamble to the Act: “It is the policy and objective 
of the Congress to use the patent system to promote the utilization of inventions arising 
from federally supported research or development” ("Bayh-Dole," 1980, § 200).  Cohen 
et al. (2002) have demonstrated the original argument for the Bayh-Dole Act was 
misaligned with the facts, which reinforces the relevance of the research objectives of this 
study. 
The actual growth and prevalence of TTOs is relatively new (i.e., since 1980), and 
it appears that the Bayh-Dole Act is the precipitating event for this occurrence.  In Figure 
2, there is a noticeable transition point in the growth of university technology transfer as 












Figure 2. The proportion of Carnegie Research Universities employing greater than .5 
full-time equivalent, technology-transfer personnel.  Graph adapted from Mowery et al. 
(2004, p. 48) with permission, copyright Stanford University Press. 
 
While TTOs emerged from the Bayh-Dole, it is unclear if Bayh-Dole has yielded 
the desired effect on the underlying patenting activity of universities it was designed to 
enhance.  Evidence suggests, “That the growth in university patenting predates Bayh-
Dole” (Mowery et al., 2004, p. 48).  Figure 3 plots the number of university patents 
applications per dollar of R&D expenditure over time and a positive growing trend 
(dashed line) is visually apparent commencing around 1971, approximately ten years 
prior to the enactment of Bayh-Dole in December of 1980.  This already-present growth 
pattern tends to negate the reported level of success otherwise credited to the Bayh-Dole 
legislation.  According to Mowery et al., this prior trend in patent applications can be 
attributed to a combination of factors that includes timing of substantial advances into the 
biomedical sciences contemporaneously with changes in the legal treatment on life forms 








Figure 3.  University Patenting Activity per R&D Dollar.  Patent activity is represented 
by the number of non-provisional patent applications filed in a given year, whereas R&D 
represents research expenditures for the calendar year prior to the patent.  Graph adapted 
from Mowery et al. (2004, p. 49) with permission, copyright Stanford University Press. 
 
Operating Mandate and Funding of TTOs 
 According to Abrams, Leung, and Stevens (2009), “when university presidents 
speak publicly on the commercialization of technologies, they focus more on the public’s 
right to see a return on the investment of their tax dollars in research grants via the 
availability of new products and services [as per the objectives of Bayh-Dole], rather than 
on the financial return that they might hope to see” (p. 4).  For example, during an 
address by Dr. Coleman President of the University of Michigan at the 2005 Annual 
Meeting of AUTM she stated, “you heard me correctly.  It is not about the money .... 
Revenue generation is NOT the ultimate goal.  It is simply the means by which we can 
increase the transfer of new knowledge into the business sector” (Abrams et al., 2009, p. 
4).   
Abrams et al. found that the above statements by Dr. Coleman, in fact, reflected 
the general case.  Abrams et al.’s (2009) work consisted of a survey of the directors of 





response rate to a directed survey.  Of the survey responses, 112 of the respondents 
replied to every question.  From their analysis they concluded “that although a small 
number of academic institutions have reaped very large rewards from their technology 
transfer activities … these rewards appear to be a consequence of programs driven by 
broader objectives” (Abrams et al., 2009, p. 2).  
Synopsis of the U.S. University System of Technology Transfer 
What has been gleaned from this component of the literature review is the 
understanding that from the beginning, U.S. universities have taken an application driven 
approach to their mission, and as a result, technology transfer has existed throughout their 
history (Mowery et al., 2004).  In the past, the technology transfer process has taken 
many forms in order to effectively disseminate the new knowledge being generated on 
campus.  Historically, this knowledge has been able to be exploited as a public good to 
create economic and societal benefit (Kerr, 1963).  Today, TTOs represent a new 
manifestation of that dissemination process, focused specifically on the application (i.e., 
private licensing) of new knowledge contained in the form of inventions and patents.  
The difference being that this knowledge, in the form of patents, is not a public good, and 
it is being applied through selective licensing arrangements for commercial exploitation 
and private gain (Tassey, 2001).  At the highest policy levels the rationale for this activity 
(which is also contained in the preamble to the Bayh-Dole Act), is the notion that this 
private process does provide benefit to society at large through the provision of goods 
and services that would otherwise not be readily available, most notably advances in the 
life sciences (AUTM, 2011; "Bayh-Dole," 1980; Schacht, 2012).  The eventual public 




has motivated policy-makers to attempt to mitigate the Valley of Death (RFI, 2010).  A 
review, specific to our current understanding of the Valley of Death, follows.    
The Valley of Death 
The objective of this component of the literature review is to detail the evolution 
of the Valley of Death metaphor leading to its current connotations.  A valley, by 
definition, is a hollow or expanse of low ground, which forms a connecting point between 
two formations.  In the context of university technology transfer, it is the apparent 
expanse between the academic knowledge enterprise formation on one side and the 
industrial innovation enterprise formation on the other side.  Metaphorically, the Valley 
of Death reflects the final resting place for those university inventions that do not 
successfully crossover from academe to the market.  The use of the term Valley of Death 
related to technology transfer is a relatively recent occurrence.  By way of example, a 
Google Scholar search of the terms: invention, innovation, technology transfer and 
Valley of Death produced ten references for articles and books written prior to the year 
2000.  None of these ten references included the search term Valley of Death in their 
titles. 
History of the Metaphor  
Among the earliest and most cited references of the term, Valley of Death, is the 
report of United States House of Representatives, entitled “Unlocking Our Future: 
Toward a New National Science Policy” (H.R. Rep. No. 105-B, 1998).  The Vice 
Chairman of this Committee and the individual who oversaw the content of the report, 
Vernon Ehlers, has been given much of the credit for the widespread adoption of this 
metaphor, including attribution for the conceptual depiction of the Valley of Death 




the Committee report, Wessner states Ehlers used this depiction as a visual aid to explain 
the circumstances of the report:  “Vernon Ehlers, one of the few scientists in the U.S. 
Congress, described the situation [Valley of Death] with the striking image shown in 
[Figure 4 below]” (Wessner, 2005, p. 9).  Of particular note in Figure 4 is the concept of 
the need for capital to bridge new research ideas and product innovation.   
Figure 4. Image of the Valley of Death, attributed to V. Ehlers.  Adapted from “Driving 
innovations across the valley of death” by C.W. Wessner, 2005, p. 10.  Copyright 2005 
by Industrial Research Institute, Inc., with permission. 
 
 Within the 1998 report’s examination of the roles for government and the private 
sector, a concept described as a research gap emerged.  Specifically this concept was 
described as follows: “Today’s technology-driven company must bridge the research gap 
between basic science and product development if it wants to remain on the cutting edge 
of the industry” (H.R. Rep. No. 105-B, 1998, p. 39).  The research gap is a mid-level or 
applied research gap and is typically necessary to develop basic research results into an 
emerging technology, leading into a marketable product (Vest, 1996).  Contained in the 
report, and consistent with the linear model of innovation are the distinctions among 




recognized the limited resources of the federal government and accordingly reaffirmed 
government’s need to remain focused on its “irreplaceable role in funding basic research” 
(H.R. Rep. No. 105-B, 1998, p. 40). 
In the Committee’s report (H.R. Rep. No. 105-B, 1998), not only was the research 
gap recognized and defined, but it was also stated that it was expanding, “This gap, which 
has always existed but is becoming wider and deeper, has been referred to as the Valley 
of Death” (p. 40).  The explanation given for this expansion was a function of the limited 
level of federal resources on the one hand, thereby containing federal R&D funding to the 
front end of the development spectrum and market forces driving industry toward more 
short term, rapid payback periods on the other hand, thereby forcing industry to focus at 
the opposite end of the development spectrum (H.R. Rep. No. 105-B, 1998).  Within the 
report, the use of the term Valley of Death is attributed to others, but no other specific 
source reference was cited. 
The actual origin of the term, Valley of Death, as applied to the innovation 
process appears to have initially emerged from an even earlier report prepared by 
Mohawk Research Corporation for the Department of Energy and Argonne National Labs 
(Lux & Rorke, 1991).  In contrast to the purpose of the Committee on Science report (i.e., 
policy driven), the Mohawk report was to serve as a primer on the innovation process, 
and it examined considerations to be made when taking a product from the concept state 
to market entry.  The key difference between the two reports is the Committee on Science 
is discussing moving basic research (i.e., research that is not considered to have any 
identified end use or product in mind) through applied research and then into product 
development, whereas Mohawk is discussing taking a product idea (i.e., something 




the Committee’s gap commences in the applied research stage, and Mohawk’s gap 
commences in the developmental research stage.  The Mohawk version of the Valley of 
Death is, by their calculation, the summation of the negative cash flow encompassing the 
period from the start of product development through to the point of profitability derived 
from market sales.  The imagery used by Mohawk for their Valley of Death is depicted in 
Figure 5:   
Figure 5. Mohawk Research Corporation’s Image of the Valley of Death.  Adapted from 
"From Invention to Innovation: Commercialization of New Technology by Independent 
and Small Business Investors,” (Lux & Rorke, 1991, p. 19).  Copyright 1991 by Mohawk 
Research Corporation, with permission. 
 
Emerging since the time of the Mohawk and Ehlers’s depictions is a further 
evolution of the industrial sector Valley of Death.  This version was presented by 
Markham (2002), and it has been reproduced in Figure 6.  He describes the Valley of 
Death as follows: 
Most companies have the resources, personnel and organizational structure for 
technology development.  These components are present on the left side of the 
valley.  Similarly most companies possess the resources for such 




distribution, which appear on the right side of the valley.  The Valley of Death 
between discovery and commercialization thus represents a lack of structure, 
resources and expertise. (Markham, 2002, p. 31) 
Figure 6. Markham’s Image of the Valley of Death.  Adapted from " Moving 
technologies from lab to market” (Markham, 2002, p. 32).  Copyright 2002, Industrial 
Research Institute Inc., with permission. 
 
Markham’s (2002) image of the Valley of Death is a depiction of his 
interpretation of gaps in structure, resources and expertise and he defined the position of 
the Valley of Death as the “decision space between existing research resources and 
commercialization resources” (p. 32).  Since Markham focused his research on industrial 
behavior, his depiction also reflects product development occurring solely within the 
private sector innovation process.  Accordingly, his construct of the Valley of Death 
describes a shortfall of private sector resources. 
A further evolution and variation of the Markham drawing has been observed, but 
it does not yet appear to be contained within the academic literature.  It has made several 
appearances at various general conferences and popular addresses on the subject of 




Annual Summit, Indianapolis, 2011; Association of University Technology Managers, 
Eastern Annual Meeting, Baltimore, 2011; Gulf Coast Patent Association Annual 
Meeting, Mobile, 2011; I-Ten Wired Annual Summit, Pensacola, 2010; BIO International 
Convention 2010, Chicago, IL; Gulf Coast Technology Council, Spring Meeting, Mobile, 
2009, etc.).  A sample of this evolved version of the Valley of Death is captured in Figure 
7.  This depiction was retrieved from the web site of the Chancellor of the University of 
California - Davis Campus, Dr. Linda Katehi.  It formed part of her presentation on 
technology transfer at the BIO International Convention in Chicago (Katehi, 2010).   
 
Figure 7.  Katehi’s Image of the Valley of Death.  Adapted from "The role of 
universities, biotechnology companies and technology transfer in the innovation 
economy”, (Katehi, 2010, slide 7); figure entitled “The Continuum of Innovation”, used 
with permission. 
 
Dr. Katehi’s image maps the level of resources required for development against 
the level of technological development achieved.  It starts with the earliest stage of 
development (basic research) being conducted in the public domain and the end stage of 
development (a commercialized product) being generated by companies in the private 
sector.  The Valley of Death portrayed in Dr. Katehi’s image is a clear illustration of the 




potential complementary but separate groups in the overall innovation process.  Of 
further note is the use of the word continuum, which Dr. Katehi used in the title of her 
image, suggesting she sees university basic research inexorably linked to the innovation 
process. 
The most recent variation of the Valley of Death to emerge is an image portrayed 
by the NSF, refer to Figure 8 (NSF, 2013a).   
Figure 8. National Science Foundation’s Ditch of Death.  Depiction of the relative 
positioning of the Ditch of Death versus the Valley of Death (NSF, 2013a, slide 22). 
Public government document, no copyright. 
 
Consistent with prior images, the level of research resources employed is mapped 
against the stage of development.  However, it also overlays the relative positioning of 
different actors involved in the process and indicates where the various federal programs 
come into play to assist in the discovery and commercialization process.  In addition to 
this information, the NSF also adds an irregularity to the university/federal research side 
of the Valley.  They have formed a “Ditch of Death” (NSF, 2013a, slide 22) which they 




development process.  According to the NSF, this Ditch represents a gap in assessing the 
commercial feasibility of technology concepts that are in the earliest stages of 
development. 
The Current Consensus of the Valley of Death as a Funding Shortfall 
Supporting Ehlers’s original notion of a lack of capital in technology development 
(refer Figure 4), there has been an ongoing consensus in the literature the Valley of Death 
is the consequence of a shortfall in the availability of capital resources in the mid-stage of 
product development.  This consensus is captured in an early and comprehensive 
description of the Valley of Death by Frank et al. (1996): 
The “valley of death” is a concept used to refer to the situation in which a 
technology … fails to reach the market because of an inability to advance from 
the technology's demonstration phase through the commercialization phase.  The 
valley of death occurs when the developer of a particular technology has 
successfully demonstrated the efficacy of the technology but is unable to obtain 
financing [emphasis added] for the scale-up and manufacturing process.  At this 
point, the government considers the technology too “applied” to continue to 
provide funding, since the government's role is to fund more basic research, yet 
the private sector does not want to invest capital because the technology has not 
yet been implemented.  (p. 61)   
Similar styled definitions of the Valley of Death have been made in subsequent works as 
exemplified as follows: 
 “ A dearth of sources of funding …”,  (Auerswald & Branscomb, 2003, p. 
232). 




 “The ‘Valley of Death’ is the name given to the gap between the great plains 
of research funding and the orange groves of manufacturing ...” (Williams, 2004, 
p. 23). 
 “The early-stage capital gap, often called the valley of death …” (Wessner, 
2005, p. 9).   
 “The technology transfer gap has always been with us but in drug discovery 
it has widened to form a valley of death …” (Moran, 2007, p. 266).  
 “A ‘funding gap’ or ‘Valley of Death’ exists …” (Beard et al., 2009)   
 “The ‘Valley of Death’, a term used to refer to ideas that are interesting but 
too early stage to attract commercial  investment … ” (Wylie, 2011, p. 1169).  
The consistent theme throughout the foregoing cited works is a lack of funding is 
a contributing, if not, the cause of the Valley of Death.  This lack of funding has not been 
quantified by any of these authors nor have they referenced any other source that 
quantifies the funding shortfall.  Additionally, the researchers provide only a generalized 
descriptive notion of where the funding shortfall occurs, somewhere between the end of 
solving a basic research issue and the point where industry is interested in taking on 
further development of the product.  
Advancing the Funding Shortfall Model 
The work of Auerswald and Branscomb (2003), entitled “Valleys of death and 
Darwinian seas: Financing the invention to innovation transition in the United States” 
broadened the understanding of the Valley of Death.  The title still suggests funding 





The imagery of the Valley of Death … suggests a barren territory when, in reality, 
between the stable shores of the S&T [science and technology] enterprise and the 
business and finance enterprise is a sea of life and death of business and technical 
ideas, of ‘big fish’ and ‘little fish’ contending, with survival going to the creative, 
the agile, the persistent.  Thus, we propose an alternative image the ‘Darwinian 
Sea.’  (pp. 229-230)   
The metaphor of the Darwinian Sea describes an environment where survival goes to the 
most economically fit technologies.   
Auerswald and Branscomb (2003) state “whether or not efficient markets exist on 
Wall Street may be an open question.  However, efficient markets do not exist for 
allocating risk capital to early stage technology ventures” (p. 231).  This statement 
provides the key distinction between this and other works citing funding shortfalls as the 
precipitating factor of the Valley of Death.  The authors further explore the funding 
shortfall by presenting viewpoints from either side of the Valley.  On the one side, there 
is the perspective of the private sector (the demand side), which is distinguished from the 
perspective of the academic knowledge enterprise (the supply side).  In the case of the 
supply side, the funding shortfall stems from policies focusing on funding basic research 
with a lack of applied research grant opportunities.  On the demand side, industry seeks 
out capital investment through market-based mechanisms to develop early stage 
technologies and as a result the funding shortfall as a capital market issue.  The authors 
suggest that too much risk/uncertainty surrounds investment in early stage technologies, 
which directly affects the supply and cost of capital for those technologies.  To market 
suppliers of capital, the risk-adjusted rates of return on these early stage technologies are 




Building on the work of Auerswald and Branscomb (2003), Beard et al. (2009) 
utilized mathematical modeling to predict the occurrence of the Valley of Death.  Starting 
from the standard premise of the Valley as a shortfall in funding in the mid-stages of 
development, the authors provided a mathematically derived, theoretical explanation for 
the shortfall.  The study concluded the Valley of Death stems from an overinvestment in 
non-economic research at the very early stages of technology development and the Valley 
of Death should not be an unexpected consequence.  (Beard et al., 2009).  In essence, the 
Valley of Death remains a funding issue and to remove it one must either (1) substitute 
more economically driven basic research, assuming that could even be determined in 
advance, and/or (2) fund more intermediate research.  Although these conclusions may 
appear self-evident, the value of this study is provided as confirmation of Auerswald and 
Branscomb’s findings that early stage technologies are in an economic competition with 
other potentially economically feasible projects and that the fallout (i.e., the Valley of 
Death) is a result of economic forces and natural market mechanisms choosing which 
technologies to pursue.   
Despite findings for market-based economic factors as the cause of the Valley of 
Death, Beard et al. recommend public policy intervention, namely increased government 
financial support for intermediate (applied) stage projects (Beard et al., 2009).  This 
conclusion prefaces the need for a review of past and currently evolving federal policy 
aspects of the Valley of Death, which is provided in the following section. 
Federal Policy Perspectives and the Valley of Death 
The 1998 Committee on Science’s report confirmed the position of the federal 
government with respect to the Valley of Death.  Namely, it constitutes a gap between 




government has little interest, aptitude or even mandate to pursue (excluding such 
notables as national defense and healthcare).  By inference, the Valley of Death is a 
private sector concern.  The Committee on Science (H.R. Rep. No. 105-B, 1998) 
specifically elaborated on this matter as follows:   
The Mid-level research has customarily been performed, and should continue to 
be done, in the private sector.  The fruits of this research are proprietary; the 
company is the primary or even sole beneficiary of any new technologies.  At the 
same time, the company must also bear the risk that the research project will not 
yield any profitable results. (p. 39) 
The past federal policy position is consistent with the basic precepts of the U.S. 
market driven economy; market rewards go to those that take market risks.  Therefore, 
any further market-oriented development of research outputs must responsibly rest within 
the purview of the private sector (H.R. Rep. No. 105-B, 1998).  
In addition, the Committee on Science (H.R. Rep. No. 105-B, 1998) noted that the 
Valley of Death phenomenon was being exacerbated as a result of industry’s short-term 
focus on profitability and its desire for a rapid return on investment.  It observed, “The 
deployment of industry scientists on research … for which there are expected near-term 
payoffs suggests that these scientists will … not be encouraged to take part in longer-
term, more exploratory research” (p. 39).  Former Undersecretary for the Department of 
Commerce, Good, made similar observations when she previously testified at a federal 
hearing on the Department of Commerce’s technology grant programs, “Now, in this 
environment, what we find is that the competitive pressures of the global marketplace 
have forced our American firms to move their R&D into shorter-term product and 




are in the process of seeing is an innovation gap [emphasis added] and it is developing 
between the fundamental research that is done primarily at the university level … and the 
shorter-term development activities of U.S. corporations” (p. 5).  
Good’s comments and the Committee on Science report were issued 
approximately seventeen years ago, but these comments remain just as relevant today.  
According to the Global Competitiveness Report for 2011-2012, the global market place 
is considered to become only more and more competitive with innovation as the key 
driver of success.  The United States is currently ranked 20
th
 in the world in measures of 
its companies’ competitiveness in international markets (World Economic Forum, 2011).  
This is a dropping of one ranking position from the prior report and a fall from 12
th
 
position in 2008.  Despite a strategy of capturing “closest to market” innovations, U.S. 
companies are falling behind their world counterparts. 
A Shifting Policy Viewpoint Regarding Government’s Role  
The historical policy position adopted by federal policymakers and legislators is 
that the research gap/innovation gap/Valley of Death is a market driven phenomenon.  
The gap is perceived not only to continue, but it is also estimated to widen.  As a result, 
the White House issued the 2010 RFI, referenced earlier in this document, to identify 
ways in which to move technologies more effectively out of the lab and into the 
marketplace.  Within the RFI, suggestions were specifically being sought regarding what 
changes in public policy and research funding should the Obama Administration consider 
that would promote commercialization of university research (RFI, 2010, p. 14477).  The 
White House has taken the position that a research-funding gap exists and has 
acknowledged, through the RFI, financing that gap through federal programming would 




the literature on the policy-making process to provide perspective on the actions of the 
current administration and to help frame the observed movement in current federal policy 
direction.  
The Policy-Making Process 
In the past, researchers have presented models consisting of various sequential 
and iterative stages to explain the policy-making processes.  As early as 1936, Harold 
Lasswell articulated the concept of ‘stages heuristic’ to describe the process (Lasswell, 
1936).  In his model, these stages included identifying policy problems, formulating 
policy proposals, legitimizing public policy, implementing public policy, and evaluating 
public policy.  After the evaluation stage and assuming a change in outcomes is desired, 
the process repeats itself.  Refinements of the staged process model have taken place 
since Lasswell; however to date, all staged approaches have been criticized for being 
insufficient and specifically do little to explain the drivers of policy change (DiNitto, 
2011).  Staged models are mostly regarded as simply representing a process flow, but 
they have been influential in conceptualizing how people look at policy in general 
(Nakamura, 1987). 
Specific to policy change in the policy process, political scientists had perceived it 
as the outcome of strategic power struggles among political groups (Easton, 1965; 
Truman, 1951; Wilson, 1973).  Political groups hold different values and interests and 
bring different resources to bear on existing regimes to effect change.  However, in 1974 
Heclo concluded that such tactics could only account for a portion of experienced 
changes.  Heclo determined that policy change was a product of large scale social, 
economic, and political changes as well as the strategic interaction of people within a 




knowledgeable means of addressing the policy problem (Heclo, 1974).  It was found that 
government programming is primarily driven through policy analyses, which set out to 
ascertain causal theories regarding the problem being addressed (cf. Berman, 1978; 
Majone, 1980; Mazmanian & Sabatier, 1981, 1983; Wildavsky & Tenenbaum, 1981).  As 
a result, much of policy change is currently understood to be disputes over the validity of 
causal theories and the appropriateness of the underlying data supporting the need for 
change. 
Policy change theory further evolved in the late 1980s, when Sabatier argued that 
“policy change is best seen as fluctuations in the dominant belief system (i.e., those 
incorporated into public policy) within a given policy subsystem over time” (Sabatier, 
1988, p. 158).  This premise forms the basis of Sabatier’s ACF.  In the context of ever-
changing information and events, ACF empirically seeks to explain the dynamic 
processes of policy learning and policy change through policy subsystems and the 
formulation/re-formulation of coalitions that occupy those subsystems based on common 
beliefs (Sabatier, 1988).  ACF now appears to be the most dominant method of analysis 
of policy-making by scholars around the world (Weible, Sabatier, & McQueen, 2009).  
Recent work emerging from the literature, and complementary to ACF, is a class 
of study known as NPF.  NPF utilizes the role of narrative elements as a mechanism to 
explain ACF’s policy subsystems, advocacy coalitions, shared beliefs, and public opinion 
(Shanahan, Jones, & McBeth, 2011).  NPF centrally locates the role of policy narratives 
in ACF.  As a developing framework, NPF is informed by theories from a number of 
disciplines and academic fields (cf. Riker, 1986; Sabatier & Jenkins-Smith, 1993; 




captures and describes policy narratives, but also helps assess the influence of policy 
narratives on public opinion and policy outcomes (Shanahan et al., 2011). 
According to Shanahan et al. (2011), narrative elements can be classed as 
variables to serve as quantitative measures providing a means of assessment.  Proponents 
of NPF contend it better illuminates facets of the policy process (McBeth, Shanahan, 
Arnell, & Hathaway, 2007).  The basis by which stakeholders ascribe meaning to a 
situation can be best captured through an empirical investigation of the stories that the 
policy sub-systems strategically deploy and Shanahan et al. (2011) state, “stakeholders 
use words, images, and symbols to strategically craft policy narratives … to produce a 
winning coalition” (p. 536).  Therefore, the inclusion of policy narratives as causal 
variables in the policy change process is both valid and necessary (Shanahan et al., 2011). 
Summary 
The literature reveals that the success rate of TTO activity is falling short of 
expectations, and the failure of TTOs to transfer most inventions to industry is reflected 
in a phenomenon characterized as the Valley of Death.  The Valley of Death metaphor 
provides an intuitive conceptualization of university inventions falling short of the 
market.  It can be concluded that the majority of work finds that there is a funding 
shortfall in the mid-stages of the development cycle, causing the premature death of 
many inventions.  This funding gap is a product of both the current government grant 
structure and the operation of private sector capital markets, and if the funding gap were 
to be filled, then far more university inventions would find their way to market.  The 
literature review finds the work to date falls short of any quantified assessment of the 
funding shortfall, or confirmation where this shortfall may be located along the 




Further evidence from the literature suggests that, commencing with the Bayh-
Dole Act itself, past policy positions on technology transfer have been misinformed.  In 
addition, the shared beliefs that currently exist and which are now driving policy change, 
appear to have limited empirical foundation and as such may hold similar, potential 
misconceptions of the true underlying nature of the problem.  Without appropriate 
underpinning analysis, current policy direction may be counterproductive.  Through the 
literature review, key gaps in the knowledge base have been identified which validate the 





RESEARCH DESIGN AND METHODOLOGY 
Introduction 
As evidenced in Chapter II, the academic consensus is that the Valley of Death is 
precipitated from a funding gap in the mid-stages of the R&D process (cf. Auerswald & 
Branscomb, 2003; Frank et al., 1996; H.R. Rep. No. 105-B, 1998; Murphy & Edwards, 
2003).  This funding gap is intuitively understandable since the focus of university 
research (i.e., approximately 80% of federally funded R&D) occurs at the basic research 
end of the innovation spectrum, whereas industry’s focus (i.e., approximately 80% of 
industrial R&D spending) is at the developmental end (NSF, 2011).  The comparative 
polarization of research activity by each sector, coupled with a relative lack of 
overlapping funding in the middle produces the gap known as the Valley of Death.  A 
concern with the current state of understanding is that beyond a basic description and an 
easily conceptualized notion, little empirical evidence supports the accepted position of a 
funding shortfall interrupting the mid-stages of development and being the precipitating 
cause of the Valley of Death.  Compounding the current situation, evolving federal policy 
direction on research grant funding appears to be promulgated based on this basic causal 
belief. 
Knowing that policy decision making is founded on the application of shared 
beliefs (Sabatier, 1991), driven by policy narratives (Shanahan et al., 2011), it is 
important to understand how these underlying aspects of the policy process may apply to 
current policy direction with respect to the Valley of Death.  Consistent with ACF and 
NPF principles, the prevailing policy narrative needs to be congruent with the empirical 




role in shaping shared beliefs and coalitions (Sabatier & Weible, 2007) and provides 
credibility to the policy narrative (Shanahan et al., 2011).  Recognizing these 
relationships, the study objectives first confirm the shared beliefs currently motivating 
policy direction and then derive an empirical model of the Valley of Death to determine 
if its actual characteristics are congruent with those shared beliefs.  The understanding to 
be gleaned from these objectives will either confirm or help re-inform U.S. federal policy 
on the funding and commercialization of university research.   
Given the variations in research objectives, the study methodology incorporates a 
mixed-method approach.  Research objective 1 requires a qualitative review of the 
content of the Congressional Record to capture the relevant data for the desired frequency 
analysis (quantitative) on the concept of the Valley of Death in the innovation sequence.  
The data retrieved is further qualitatively refined under research objective two and 
subjected to quantitative assessment to ascertain the meaning being attributed to the 
Valley of Death.  Research objective 3 is accomplished strictly through quantitative 
analysis of the data obtained under research objective one.  Research objective 4 is also 
examined under a strictly quantitative lens, although applied to a different data set than 
research objectives 1, 2, and 3.  The data analysis procedures employed under each of the 
research objectives is explained in greater detail in the following section. 
Data Analysis Procedures 
Research Objectives 1, 2, and 3 – Narrative Policy Framework and the Valley of Death  
The first three research objectives are investigated by analyzing data obtained 
through a deductive, structured content analysis.  This analysis determines the contextual 
meanings (qualitative) and frequency of use (quantitative) of the term Valley of Death in 




responsible for directing policy.  For this purpose, the U.S. Congressional Record from 
the 102
nd
 Congress (1991) through to the current session, 113
th
 Congress, forms the 
source of data for examination (Library of Congress, 1995) because this covers the period 
when the Valley of Death came into usage.  The relevant passages in the Congressional 
Record are extracted as individual text units for the analysis.   
It is known that a great deal of negotiation and deal-making occurs prior to 
Congress’ full-body debates on an issue, and many argue that roll call votes (Schroedel & 
Jordan, 1998) or personal interviews (Dodson et al., 1995) may provide better insight into 
politicos’ true beliefs.  But, the best way to assess the beliefs of the state’s politicians and 
policy-makers is through their prepared speeches (Schafer, 2000).  Hancock (2004) 
supports this stance as she notes, “a member’s remarks furnish not only his or her stance 
(pro or anti) on proposed legislation, but the arguments and ideological justifications for 
their positions.  It is in these justifications that the unacknowledged social meaning of 
public identity lurks” (p. 89).  According to Hancock, public identity is a social cognition 
formed from “the product of thinking about things, forming object-specific impressions 
and communicating about them with other people” (Hancock, 2004, p. 89).  From this 
point of view, the Congressional Record forms a logical and legitimate source to 
ascertain the true beliefs surrounding the concept of the Valley of Death. 
The content analysis started with partitioning the use of the term, Valley of Death, 
into two mutually exclusive categories (1) ‘Innovation and Technology Transfer’ and (2) 
‘All Other Contexts’ (e.g., prayer).  Once isolated in this fashion, the Innovation and 
Technology Transfer category is then further subdivided according to its contextual 
meaning, with all statements that relate to a ‘funding issue’ grouped together.  By 




to the frequency of other uses of the term, the overall prevailing shared belief of the 
Valley of Death is identified.  Further sub-categorization to account for the location of 
the Valley of Death along the innovation spectrum helps to additionally frame the 
understanding of the term.  This methodology also provides a ranked measure of all 
definitions of the term, relative to each other. 
Use of content analysis is well founded in the literature and according to Titscher 
et al. (2000), content analysis is "the longest established method of text analysis among 
the set of empirical methods of social investigation" (p. 55).  While its approach 
originally focused on methods that targeted clearly quantifiable aspects of text content 
(e.g., absolute and relative frequencies of words per text), the concept was extended to 
include all those procedures which operate with categories and similarly seeks to quantify 
those categories by means of a frequency analysis (Titscher et al., 2000).  This 
methodology has been previously employed in studies ranging from an analysis of debate 
in the U.S Senate (Lehnen, 1967) to changing definitions in social issues (Cook & 
Skogan, 1984) to social movements (Polletta, 1998) to poverty (Hancock, 2004).  While 
many examples of content analysis exist, each of the foregoing references was cited 
because their content analysis was specifically drawn from the U.S. Congressional 
Record as was conducted herein.  In addition, Jones and McBeth (2010), specifically 
propose content analysis of the Congressional Record for the study of policy narratives to 
determine public opinion on policy matters.  
Elo and Kyngas (2008) state there are two types of content analysis, inductive and 
deductive.  Inductive content analysis is used when there is little perceived knowledge 
about the phenomenon under study.  Deductive content analysis is used when the 




theory testing.  In this case, deductive content analysis forms the methodology proposed, 
since the subject matter has been previously defined and knowledge already exists 
regarding the perceived cause of the Valley of Death.  Deductive content analysis is 
operationalized through a coding process (Babbie, 2001) where raw data is transformed 
into a standardized form.  This transformation consists of reducing texts into a matrix and 
analyzing that matrix quantitatively.  The researcher produces such a matrix by applying 
a set of codes to a set of qualitative data (Ryan & Bernard, 2000).  The object matter of 
content analysis can be any kind of recorded communication, namely transcripts of 
interviews/discourses, protocols of observation, video tapes, and written documents in 
general (Kohlbacher, 2005).  The analysis may also take the form of either a structured or 
an unconstrained format.  When using a structured matrix of analysis, only the aspects 
from the data that fit the categorization framework and dimensions are employed (Elo & 
Kyngas, 2008).     
This study’s content analysis of the Congressional Record was initiated utilizing 
the Library of Congress’ on-line text search engine to identify individual instances of the 
use of the term Valley of Death.  The complete content of each edition of the 
Congressional Record containing the term was retrieved through the web site 
http://beta.congress.gov.  These source documents form the raw data input for analysis 
using the content analysis software NVivo (NVivo, 2013).  Within NVivo, the captured 
editions were categorized based on the contextual use of the term.  Instances where 
Valley of Death was affiliated with innovation and technological development formed a 
category for further analysis, while all other uses were discarded.  Classification in this 




The mechanism used for further analysis of the relevant documents followed the 
methodology employed by Hancock in her study of poverty in America (Hancock, 2004).  
She examined the Congressional Record as source input to create what she called the 
public identity of poverty.  To gather appropriate content for her analysis she established 
certain ‘dimensions’ which are descriptors that are considered to be commonly associated 
with poverty.  For example, her dimensions included such terms as: don’t work, lazy, 
cross-generation dependency, single-parent family, drug users, teen mothers, etc.  A 
search of the Congressional Record under these dimensions provided the starting content 
for her detailed data analysis.  In parallel fashion, research objectives 1 and 2 of this 
study are designed to confirm the public identity of the term Valley of Death.  To isolate 
the relevant content from the Congressional Record and address research objective 1, the 
following dimensions were established as the criteria for the Valley of Death related to 
innovation and technology development: research, development, R&D (in case 
abbreviations were used in the text), innovation and technology.  The actual roots of these 
words were used in the search of the text to allow for variations in usage.  For example, 
‘innovat’ was used to generate results from such words as innovate(s), innovating, 
innovative, innovation, etc.  These dimensions were chosen from the descriptions in the 
literature review based on the fundamental understanding of the Valley of Death related 
to the linear model of innovation.  All passages containing instances of the term Valley of 
Death associated with one or more of the dimensions noted above were identified and 
captured to produce the content considered appropriate not only for research objective 1, 
but also for further analysis under research objectives 2 and 3. 
With respect to research objective 2, the instances of the selected text content 




factors used to describe the Valley of Death such as a funding issue or not and/or if a 
position along the innovation spectrum was mentioned for its location.  The dimensions 
used to specify funding issues were set as a group of synonyms around availability of 
capital, specifically – funding, financing, money, capital, investment, loans, credit and 
grants.  The dimensions established to examine for the location of the Valley of Death 
were commercialization, ideas, applied research, products, between, bridge, and market.  
The terms for the position dimension were drawn from a generalized statement of 
understanding of the literature, whereby additional resources are required to 
commercialize ideas into market products and bridge the applied research gap between 
basic and developmental research.  As with research objective 1, the roots of the words 
forming the dimensions for research objective 2 were used as the search terms to isolate 
the relevant text.  If one or more of the supporting dimensions were located within the 
text under examination, then that text was selected as fulfilling the criteria to describe 
that particular factor.  The selected text units supporting a factor were then quantitatively 
assessed against all text units obtained under research objective 1 to determine the 
relative importance of that factor vis-à-vis all other discussion.  
Under research objective 3, the findings for use of the term Valley of Death, in 
the context of innovation and technology development (i.e., the pertinent findings of 
research objective 1), were then aggregated by year of occurrence and relative frequency 
of use calculated.  
Research Objective 4 - Empirical Basis of the Valley of Death  
The methodology employed for this research objective utilized a post facto, non-
experimental approach (Sprinthall, 2006) to determine the historical R&D spending 




on the use of descriptive statistics of each of the categories of R&D spending over the 
period of 1998 through 2011 to generate the model.  Referencing the various figures 
provided in Chapter II, the Valley of Death has been typically illustrated on a two-
dimensional graphical plane such that the abscissa reflects the technological stage of 
development, or phase of research, while some measure of R&D resources expended is 
presented on the ordinate axis.  On this plane, figurative renderings of the R&D spending 
patterns for both universities and industry have been depicted as separate s-shaped curves 
(mirroring the sides of hills), and the apparent horizontal gap between these curves has 
been dubbed the Valley of Death (Katehi, 2010; Markham, 2002; NSF, 2013a).  By 
utilizing these standard depictions as the base model and by applying both the academic 
and industrial sectors’ actual past R&D spending patterns, a first-hand quantification of 
the underlying structure of the Valley of Death phenomenon is produced.  To provide the 
reader with clearer understanding of the standard R&D spending model and the one used 
in this study, a visual portrayal of its general underlying structure is illustrated in the two-





Figure 9.  The standard graphical plane used to depict the Valley of Death for the 
comparisons of patterns of R&D spending between the university and industrial sectors. 
 
From Figure 9, the three categories of research are seen to sequentially align and 
build on each other along the x-axis, reflective of the linear model of innovation.  As laid 
out in Chapter II and according to Godin (2006), the linear model contends that 
innovation starts with basic research, moves through applied research and then to 
developmental research, ending up with production and market diffusion.  Prior to any 
research spending the stage of development is considered as solely an idea depicted as 
point X0 at the origin of the x-axis in Figure 9.  After proceeding through the various 
R&D phases, and once all the stages of development are concluded, the technology is 
ready for production and market distribution depicted as point X1 at the extreme right of 
the x-axis in Figure 9.   
The y-axis of the graph represents the measure of R&D spending.  As shown in 
Figure 9, it is typically the percentage amount of the total spending in each category of 
research by sector (Katehi, 2010; Markham, 2002; NSF, 2013a).  By utilizing the 










































calculating its percentage relative to sector total spending, the data presents the overall 
historical spending pattern for both the university and industrial sectors.  Each sector 
results were individually calculated and presented and a trend line was attached to the 
results.  Next, the percentage results for each sector category were superimposed on each 
other, and when constructed in this fashion, the x-y plane and accompanying trend lines 
provided the necessary vehicle to depict the historical patterns of spending for both the 
university and industrial sectors, in a manner consistent with prior published renderings.   
Advancing from the initial depiction, which provided an empirically based 
rendition of the currently accepted model of the Valley of Death, a second level of 
analysis was conducted by utilizing absolute dollar spending levels.  The y-axis was 
amended to represent the actual dollar-spending amount by category, instead of relative 
percentage spending by category.  In this way, all individual categories of research 
spending, within and across sectors, were equally scaled and directly compared to each 
other.  Continuing from this second level of graphical analysis, the model was further 
adjusted to reflect the level of university R&D spending associated with the inventions 
that it produces.  The information to conduct this further modification was obtained from 
estimates of the number of inventions (AUTM, 2011) and the average federal grant 
associated with those inventions (NIH, 2013b; NSF, 2013b).  This refinement is a further 
logical extrapolation of the model, since only research associated university inventions is 
relevant to the Valley of Death.  The research inventions disclosed to TTOs are what 
must subsequently traverse the Valley of Death to be adopted by industry.  This 
subsequent adjustment and rendition provided a direct comparison between the university 
invention enterprise and the industrial innovation enterprise and hence a true final 




Population and Sample 
Recognizing the differing styles of analysis and sources of data for the study 
objectives, the discussion of the population and sample has been sub-divided.  In this 
regard, research objectives 1, 2, and 3 have been combined and will be discussed 
separately from the discussion of research objective 4:  
Research Objectives 1 through 3 
The population for these research objectives consists of all policy narratives of 
federal legislators and policy-makers engaged in advocating for or against policy on the 
Valley of Death related to innovation and technological development.  The sample used 
to represent narratives for this population was obtained from the Congressional Record 
during the period covering the 102
nd
 Congress (1991) through the 113
th
 Congress (2013).     
Research Objective 4 
Under this research objective, a comparison of R&D spending patterns between 
two statistically, mutually exclusive sub-populations was analyzed over the period 
between 1998 and 2011.  The first sub-population is represented by U.S. based research 
universities, whereas the second sub-population consists of U.S. private sector 
corporations conducting R&D within the U.S.  The university sub-population sample 
consisted of a census survey of the entire universe of U.S. research universities, 
performing R&D in excess of $150,000 per year (N=912).  The historical data have been 
collected by the NSF from each accredited institution in this sub-population and are 
available on line at the NSF website (NSF, 2011). 
With respect to the second sub-population, namely U.S. corporations conducting 
domestic R&D, the NSF estimates the total population count of this group to be 




for-profit, nonfarm companies that are publicly or privately held, have five or more 
domestic employees, perform or fund R&D, or engage in innovative activities in the 
United States.  The NSF produces a countrywide profile of R&D spending for the 
corporate sub-population through annual survey instruments.  For example, 43,002 
companies were sampled by the NSF in 2011 with 40,300 companies incorporated in the 
final data evaluation.  Reasons for the initial elimination of certain companies from the 
sample reflect mergers, acquisitions, and instances where companies have gone out of 
business in the interim.  Of the companies included in the final data evaluation, 73.1% 
were considered to have met the full criteria for a complete response to the 2011 survey.  
The final sample (n) of 29,459 fully valid responses measured against the overall 
population estimate represents 1.5% of the total estimated population.   
Data Collection and Variables for the Study 
Data Collection - Research Objectives 1 through 3 
For these research objectives, data was sourced through a structured content 
analysis of the Congressional Record for the period covering the 102nd Congress (1991) 
through the 113th Congress (2013).  Using this time period serves two purposes, first it 
covers the period from the initial use of the phrase Valley of Death in an innovation 
context (Lux & Rorke, 1991), and secondly, it is fully accessible and retrievable 
electronically through the web site portal Thomas.gov.  All data are categorical. 
Thomas.gov is a service of the Library of Congress that was launched in 1995 to 
make federal legislative information freely available to the public.  Included among the 
data available is the Congressional Record (Library of Congress, 1995).  The 
Congressional Record is a verbatim account of the floor proceedings of the House and 




Extensions of Remarks include additional legislative statements not actually delivered on 
the House floor, plus other extraneous material such as texts of speeches delivered 
outside Congress, letters from and tributes to constituents, and newspaper or magazine 
articles.  Similar extraneous material from Senators is inserted in the Additional 
Statements section of the Senate part of the record.  The Congressional Record therefore 
provided a highly relevant source to extract details of the discussion and narratives about 
the Valley of Death within the political and policy-making environment. 
Data Collection - Research Objective 4 
The data utilized for this component of the study consists of ordinal and interval 
data drawn from three independent third-party sources: the NSF, NIH and AUTM.  These 
sources represent two federal agencies and an industrial source, respectively.  The NSF 
data provided the initial information for the analysis used to determine the fundamental 
historical patterns of R&D spending for each sector (ordinal).  The NIH and AUTM data 
enabled a refinement to the results to represent a more accurate estimate of the amount of 
R&D associated with university inventions related to technology transfer (interval).  
Details of each data source follow. 
The NSF dataset.  The data were derived from annual surveys conducted by the 
NSF, initially through its Division of Science Resources Statistics and now through its 
National Center for Science and Engineering Statistics.  Specifically, the data were drawn 
from the reports contained in National Patterns of R&D Resources, detailing R&D 
performance and funding in the United States.  The NSF's statistics on R&D expenditure 
levels have been recorded annually since 1953 and have been categorized by: (1) R&D 
performers (i.e., business sector, federal government, federally funded research and 




sources of R&D funding (i.e., business sector, federal government, nonfederal 
government, universities/colleges, and other nonprofit organizations); (3) the character of 
work performed, that being the category of research undertaken (i.e., basic, applied, and 
developmental research) and; (4) the monetary basis (i.e., recording of the expenditures 
in both current dollars and constant inflation-adjusted dollars).  The raw data extracted 
from the NSF reports and utilized in this study have been reproduced and tabulated in 
Appendixes B and C herein. 
Data covering the industrial sector are reported on a calendar-year basis to NSF 
and are used directly in the national pattern totals.  The data for universities and colleges 
are collected on the institution’s fiscal-year basis and then converted to a calendar year by 
NSF prior to publication.  In 1998 and later years, the university R&D figures were 
adjusted to eliminate double counting of funds passed through from one academic 
institution to another.  For university/college R&D, the character-of-work estimates were 
also revised for 1998 and later years.  According to the NSF, the revised procedure along 
with respondent data corrections yielded an increase of approximately five percentage 
points in the share of academic R&D identified as basic research.  Similarly, the 
character-of-work estimates (i.e., basic, applied, and development research) for the 
industrial sector were revised for 1998 and later years.  These changes resulted in a net 
decrease in the proportion of business R&D classified as basic research.  In view of the 
changes to survey methodology, and unless otherwise suitably adjusted, the basic 
research data for 1998 and later years are not explicitly comparable with data for 1997 
and earlier years (NSF, 2011).  Given the changes in survey methodology, research 




recent structure of the Valley of Death and yield the most reliable comparison between 
sectors and categories. 
The AUTM dataset.  AUTM data were drawn from annual surveys of its members 
who report on the level of their respective institution’s activities.  The membership in the 
U.S. responding to the 2011 survey represented 160 research universities that conducted 
95% of all federally funded research granted in that year (AUTM, 2011).  From the 
AUTM surveys, the data on the total number of invention disclosures, in conjunction 
with the NIH and NSF average grant data sets (see below), formed the basis for 
estimating the total amount of federal R&D funding attributed to university inventions.  
This provided a method for defining the level of university R&D spending relevant to the 
commercialization process.  All raw data captured from the surveys and utilized in the 
analysis are compiled in Appendix D. 
The NIH dataset.  Additional data to further refine the pattern of R&D spending 
for universities was drawn from the NIH Research Portfolio On-line Reporting Tools 
(NIH, 2013b).  This public, on-line, searchable database provides information on 
historical grant awards by the NIH.  The data obtained from this database represents the 
total number of NIH grants and the total dollar amount of those grants awarded to all US-
based, higher education institutions over the period of 1998 through 2011, inflation 
adjusted to 2005 dollars.  The data gleaned from the online database has also been 
incorporated in Appendix D.     
NSF individual grant dataset.  This additional data, when used in conjunction 
with the NIH dataset discussed above, further helped refine the pattern of R&D spending 
for universities.  It was drawn from the NSF web-based Budget Internet Information 




historical grant awards by the NSF.  The data obtained from this database represents the 
total number of NSF grants and the total dollar amount of those grants awarded to all US-
based, higher education institutions over the period 1998 through 2011, inflation adjusted 
to 2005 constant dollar levels.  The data gleaned from the on-line database has also 
incorporated in Appendix D.  
Variables - Research Objectives 1 through 3   
The variables under examination consisted of researcher-designed categories to 
accumulate counts of contextually defined terms as they were found within the official 
archived text of the Congressional Record.  The primary division of categories was 
between the uses of the term Valley of Death in the context of innovation versus all other 
use of the term.  All descriptions of the Valley of Death in the context of innovation were 
then divided into sub-categories.  For example, a description of the Valley of Death (in 
the context of innovation) as a funding shortfall was placed in one sub-category, whereas 
the description of the Valley of Death as something other than a funding shortfall was 
placed in a separate category.  Likewise, additional categorization related to the position 
of the Valley of Death along the innovation spectrum was sub-categorized whenever 
possible.  The amount of sub-categories was originally established as open-ended to 
account for all potential descriptions.  All variables are categorical (Sprinthall, 2006).   
Variables - Research Objective 4 
The variables under this research objective represent two sub-population 
groupings representing the university and industrial sectors.  Within each sector is a sub-
division of the data into the classifications of basic, applied, and developmental research.  
The values for basic, applied, and developmental research represent the amount of annual 




in absolute dollar terms.  In addition, a further sub-grouping within the university sector 
was established for R&D spending related solely to invention disclosures.  This 
categorized structure yielded fifteen separate variables utilized in analyzing the Valley of 
Death.  Tables 2 and 3 summarize the variables for both the industrial and university 
sectors, respectively.   
The dollar amounts of research in the university sector reflected only the federally 
funded portion of research at U.S. universities.  In the industrial sector, the variables 
represented domestic U.S. corporations conducting R&D, but the value of the R&D 
included only private sector sources of funding.  Thus, the resulting comparison among 
variables was between federally funded, university knowledge generating research and 
purely economically motivated research.  All other sources of grants to the university and 
industrial sectors were removed to narrowly focus the interaction of these two sectors and 




Schedule of Industrial Sector R&D Spending Variables1,2 
 




The average annual percentage of total industrial research spent 
on basic research. 
Applied % 
 
The average annual percentage of total industrial research spent 
on applied research. 
Developmental % 
 
The average annual percentage of total industrial research spent 















The average annual dollar amount of total industrial research 
spent on basic research. 
Applied $ 
 
The average annual dollar amount of total industrial research 
spent on applied research. 
Developmental $ 
 
The average annual dollar amount of total industrial research 
spent on developmental research. 
 
1. Averages taken over the period 1998 through 2011 





Schedule of University Sector R&D Spending Variables
1,2 
 




The average annual percentage of total university research spent 
on basic research. 
Applied % 
 
The average annual percentage of total university research spent 
on applied research. 
Developmental % 
 
The average annual percentage of total university research spent 







The average annual dollar amount of total university research 
spent on basic research. 
Applied $ 
 
The average annual dollar amount of total university research 
spent on applied research. 
Developmental $ 
 
The average annual dollar amount of total university research 




Table 3 (continued). 
 
Character of Spending Definition 
Basic Invention $ 
 
The average annual dollar amount of total university research 
spent on basic research related to invention disclosures. 
Applied Invention $ 
 
The average annual dollar amount of total university research 
spent on applied research related to invention disclosures. 
Developmental 
Invention $ 
The average annual dollar amount of total university research 
spent on developmental research related to invention 
disclosures. 
 
1. Averages taken over the period 1998 through 2011 
2. Dollar amounts are in inflation adjusted, constant 2005 terms 
 
While the data was originally collected annually on a current dollar value basis, it 
has been recorded by the NSF on both a current and constant dollar basis.  The actual 
statistical analysis used in the study relied solely on the constant dollar values.  The 
rationale for this approach stems from the fact that basic research is antecedent to applied 
research and applied research is antecedent to developmental research (Godin, 2006).  
The use of constant dollar terms lessened potential variability in the analysis brought on 
by inflation-induced effects on the spending over time, given the noted temporal 
sequence of the research.  Constant dollars were calculated utilizing 2005 as the base 
year, and changes in the U.S. annual consumer price index acted as the adjustment factor 
(NSF, 2011). 
The survey instruments utilized by the NSF to tabulate the data for each of the 
academic and industrial sectors contained slightly different governing definitions for the 
categories of basic and applied research.  Differences were designed to help respondents 
more accurately categorize their research activity.  The definitions contained in each of 




Basic research.  Within the federal, university, and nonprofit sectors, basic 
research is defined as research directed toward increases in knowledge or understanding 
of the fundamental aspects of phenomena and of observable facts without specific 
application toward processes or products in mind.  For the industry sector, basic research 
projects are defined by original investigations for the advancement of scientific 
knowledge, which do not have specific commercial objectives, although they may be in 
fields of present or potential interest to the reporting company.  
Applied research.  Within the federal, university, and nonprofit sectors, applied 
research is defined as research directed toward gaining knowledge or understanding 
necessary for determining the means by which a recognized and specific need may be 
met.  The applied research definition for the industry sector includes research projects 
which represent investigations directed to discovery of new scientific knowledge and 
have specific commercial objectives with respect to either products or processes. 
Development Research.  The survey definition of development research for both 
sectors is the systematic use of the knowledge or understanding gained from research 
directed toward the production of useful materials, devices, systems, or methods, 
including design and development of prototypes and processes.  It excludes quality 
control, routine product testing, and production.  This definition is consistent throughout 
the various survey instruments employed. 
Summary 
The failure of most university inventions to achieve commercial success is 
captured by the metaphor Valley of Death, which holds certain connotations and beliefs 
in the mind’s eye of policy-makers.  Policy-making is directed by a coalition of shared 




university research grants, the study objectives were designed to firstly confirm policy-
makers’ current shared beliefs concerning the Valley of Death.  Secondly, an empirical 
assessment of the Valley of Death was compared to the prevailing shared belief to 
determine if there was any disconnection between historical evidence defining the Valley 
of Death and the perception of policy-makers.  The population under investigation 
consisted of federal policy-makers (research objectives 1, 2, and 3) and universities and 
industries that had engaged in R&D activity (research objective 4).  All data used in the 
study was obtained from third party archival records and was employed in a mixed-








This chapter presents the results of this study.  The research objectives were 
designed to determine if the accepted beliefs held by policy-makers surrounding the 
cause of the Valley of Death differ from the historical evidence.  The research focused on 
the Congressional Record as the source of data to ascertain the prevailing perceptions of 
policy-makers with respect to the nature and cause of the Valley of Death.  To 
authenticate these perceptions, past R&D spending patterns of university and industry 
were examined to provide an empirically based model of the Valley of Death, which has 
otherwise not yet been portrayed in the literature.  Together these research objectives 
demonstrate the congruence of federal policy beliefs and the proposed methods of 
addressing the Valley of Death with the historical evidence on the matter. 
Findings 
Research Objective 1 
Research objective 1 was established to determine the frequency of use of the 
term Valley of Death by policy-makers in the context of innovation and technology 
development.  The search engine provided by Thomas.gov was used to identify each 
issue of the Congressional Record that contained the phrase.  The results revealed 118 
instances of the term being used over the period January 1, 1991 through November 30, 
2013.  The term appeared in 73 individual issues of the Congressional Record, uttered by 
92 different speakers.  Distillation of these results to obtain the use of the phrase in the 
context of innovation and technology development was achieved by filtering all records 




development, R&D, innovation and technology.  Specific to this context, it was revealed 
that 58 speakers utilized the phrase 79 times in 41 editions of the Congressional Record.  
The coding results for each dimension, cross-referenced to each text unit, are provided in 
Appendix E, along with the observed number of appearances in each passage for each 
dimension.  A summary schedule of the number of occurrences of each dimension and its 
relative percentage are presented in Table 4.  Note that the total number occurrences of 
the selected dimensions (235) exceeds the number of text units examined (118), 
indicating an average of 2.0 dimensions per text unit.   
Table 4 
 
Summary of Occurrences of the Dimensions Established to Capture 






% Frequency of Occurrence 
 
Research 78 33.2% 
Development 48 20.4% 
R&D 9 3.8% 
Innovation 26 11.1% 
Technology 74 31.5% 
 
Total 235 100.0% 
 
1.  Period covering January 1991 through November 2013 
 
 A manual check of the results was undertaken by reviewing all selected 
occurrences of the phrase to confirm that the content did relate to the Valley of Death in 
innovation.  The manual check confirmed that no inappropriate selections had been 
included with the results.  In a similar fashion, all unselected occurrences were 
individually reviewed for correctness.  In this regard, it was determined that five uses of 
the phrase had been inappropriately excluded from the sample.  The five instances were 




instance) and February 2, 2011 (three instances), and they were manually added to the 
sample for further consideration and analysis, increasing the overall total of valid 
instances to 84 (refer to Table 5).  The examination of these additional records revealed 
that they each referred to funding the innovation Valley of Death without having 
incorporated any of the dimension terms included in the narrative.  It was also noted that 
no new single term could have been added to the list of dimensions to capture these text 
units on the first pass.  The full chronological list of all instances of the term emerging 
from the Congressional Record is provided in Appendix F.  The list also identifies each 
use of the term in the context of innovation and technology development as well as the 
other contexts related to the use of the Valley of Death.  The details of the findings 
contained in Appendix F are summarized in Table 5 below: 
Table 5 
 







% Frequency of Occurrence 
 
Innovation/Technology 84 71.2% 
Military Tribute 16 13.5% 
Military Action 12 10.2% 
Congressional Procedures 2 1.7% 
Other 4 3.4% 
 
Total 118 100.0% 
 
1. Period covering January 1991 through November 2013 
 
From Table 5, out of all instances of the observed use of the term Valley of Death, 
the connection to innovation and technology development occurs 71.2% of the time (i.e., 
84 out of 118 times).  Other uses of the phrase were mostly in reference to descriptions of 




relevant references to the Valley of Death (i.e., in an innovative context), along with the 
surrounding narratives gleaned from the Congressional Record, were captured and 
formed the sample text units for further review and analysis under research objectives 2 
and 3.  All captured text units have been reproduced in Appendix G,    
Research Objective 2 
Research objective 2 was established to ascertain the frequency of use of a 
funding shortfall in the middle stages of development when policy-makers describe the 
Valley of Death in technology development.  By determining the frequency of the 
association of a funding shortfall with the term Valley of Death, and its associated 
location, this research objective provides a basis for explaining the prevailing belief on 
the part of policy-makers.  The relative frequency of use of a funding shortfall against 
other descriptors provides a weighting of this belief against other potential causes.  For 
the analysis, each of the 84 instances of the use of the term Valley of Death identified in 
research objective 1 (refer to Appendix G) was examined and the surrounding content 
analyzed, first with respect to the dimensions established for funding (i.e., funding, 
financing, money, capital, investment, loans, credit, and grants) and second, the 
dimensions for location (i.e., commercialization, ideas, applied research, products, 
between, bridge, and market).  The coding results of each funding dimension are 
provided in Appendix H, whereas the coding results for each location dimension are 
provided in Appendix I.  The observed number of appearances of each dimension in each 
text unit and the corresponding count of Valley of Death occurrences are also contained 
in Appendices H and I.   
Table 6 summarizes the number of occurrences and frequency of appearance 




number of occurrences of the funding dimensions (102) exceeds the number of text units 
(84), indicating an average of 1.2 dimensions per text unit. 
Table 6 
 
Summary of Occurrences of the Dimensions Established to Identify a Funding Shortfall 
Associated with the Valley of Death 
 
Dimension 
Number of  
Occurrences 
% Frequency of Occurrence 
 
Funding 31 30.4% 
Financing 6 5.9% 
Capital 34 33.3% 
Money 8 7.8% 
Investment 15 14.7% 
Loans/Credit/Grants 8 7.8% 
 
Total 102 100.0% 
 
Next, the 84 text units from the Congressional Record were reviewed against the 
dimensions related to the location of the Valley of Death.  Table 7 summarizes the 
number of occurrences and frequency of appearance of each dimension.  In this case, 
there was an average of 1.7 dimensions incorporated within each text unit. 
Table 7 
 





Number of  
Occurrences 
% Frequency of Occurrence 
   
Commercialization 34 23.3% 
Ideas 3 2.0% 
Applied Research 30 20.5% 
Products 23 15.8% 
Between/Bridge 35 24.0% 
Market 21 14.4% 
   
Total 146 100.0% 
 




The dimensions associating the Valley of Death and funding yielded a total of 61 
out of 84 text units where instances of the two were linked in open discussion (refer to 
Table 8, lines one and two).  In essence, financial parameters were tied to the concept of 
the Valley of Death 72.6% of the time.  An example of the use of the term Valley of 
Death by politicians within the Congressional Record, which reflects these financial 
parameters was provided by Representative WU: “One of the biggest stumbling blocks to 
innovation is the technology so called Valley of Death the gap between angel funding and 
measurable venture capital, the lack of adequate private venture capital for early stage, 
high-risk, high-reward technology development” (Wu, 2007, p. H4453). 
The dimensions associating the Valley of Death and a location yielded 64 out of 
84 text units where instances of the two were linked in open discussion (refer to Table 8, 
lines one and three).  The concept of the Valley of Death in the innovation process was 
associated with the middle stages of development 76.1% of the time.  A sample of a text 
unit that contains the use of the Valley of Death in the location context is provided by  
Senator Smith (2005): “However, many times innovative research becomes victim of the 
Valley of Death by failing to advance from the research labs to application in commercial 
products and services” (p. S11745). 
Cross-tabulating the results for both the funding and location factors, it was 
revealed that in 48 (line one of Table 8) of the 61 funding instances (lines one and two of 
Table 8), the funding shortfall was specifically identified as being in the mid-stages of the 
development cycle, between the outputs of basic research and final commercialization.  
An example of this use of the term was provided by Senator Morella (2001) when she 
stated, “the program seeks to provide a critical bridge for the funding gap from 




[Advanced Technology Program] seeks to smooth the transition from invention to 
commercialization, the so-called valley of death” (p. E1378).   
Beyond a funding shortfall, 23.8% of the time (refer to Table 8, lines three and 
four) the Valley of Death was associated with market factors as its influencing cause 
(e.g., risk, market readiness, limited demand, etc.).  These market development effects are 
exemplified in comments by Senator Lieberman (2008):  
Lastly, the Accelerating Cures Act of 2008 uniquely adds resources to guide 
researchers through the Valley of Death, a stage in biomedical development 
between research and commercialization where the success of an initiative is 
dependent on feasibility and profitability that can only be established by a market 
that, by definition, has not yet developed.  (p. S3894) 
In 75.0% of these cases, the Valley of Death was still identified as being a break in the 
development cycle of new technologies, situated between basic research and market 
commercialization.   
Among all characterizations of the Valley of Death, it can be stated that a break in 
the development cycle between basic research and commercialization identified the 
location of the Valley of Death 76.1% of the time (refer to Table 8, lines one and three).  
A further example in the Congressional Record that demonstrates this belief was 
provided when Senator Bingamam (2008) stated, “this is the part of the development 
cycle of a new technology when the technology has been demonstrated at a lab or pilot 
scale and is ready to be demonstrated at a commercial scale” (p. S6444).   
No other locations to identify the position of the Valley of Death were mentioned 
in the text units (i.e., basic research).  Finally, 3.6% of the time the Valley of Death was 




summary of occurrences for all of the various characterizations of the Valley of Death in 
an innovation and technological development context are provided in Table 8. 
Table 8 
 







% Frequency of 
Occurrence 
   
(1) Funding shortfall, mid-stages of development  48 57.1% 
(2) Funding shortfall, unspecified location 13 15.5% 
(3) Market factors, mid-stages of development  16 19.0% 
(4) Market factors, unspecified location 4 4.8% 
(5) Unspecific factors 3 3.6% 
   
Total 84 100.0% 
 
1.  Period covering January 1991 through November 2013 
 
Research Objective 3 
Research Objective 3 was established to determine the pattern of use over time by 
policy-makers of the term Valley of Death in the context of innovation and technology 
development.  Based on analysis of the text units extracted from the Congressional 
Record directly related to innovation, the pattern of use of this phrase has been seen to 
cycle over time.  Typically the use of the phrase has shown greater frequency in years 
where certain legislation is up for reauthorization (e.g., Advanced Technology Program 
2005, SBIR-STTR 2009 and 2011, Cures Acceleration Network Act 2009, IRS Tax 
Credits 2011, Department of Defense Authorization Act 2011, etc.).  In the case of the 
Small Business Innovation Research and Small Business Technology Transfer programs’ 
(SBIR-STTR) re-authorization legislation, the discussion centered on the need for this 
programming to help mitigate the Valley of Death and advance the use of new 




in contrast to the original stated purpose of the legislation, which was to engage small 
business in creating innovative solutions to technological issues faced by government 
agencies ("Small Business Innovation Development Act," 1982).  Although slightly 
outside the scope of this study, this change in policy narrative is a prime demonstration of 
the precepts of NPF and ACF.  The policy narratives are now focusing on the SBIR 
program as an economic development tool, which is framing a new perception and belief 
for the need for the program.  Evidently, sufficient coalition took place around this new 
belief that the legislation was reauthorized.  
Table 9 provides details of the annual occurrence and relative frequency of use of 
the term over the study period. 
Table 9 
 






% Frequency of 
Occurrence 
Key Legislative Considerations 
    
1991-2000 0 0.0%  
2001 5 6.0% Advanced Technology Prog. 
2002 0 0.0%  
2003 0 0.0%  
2004 4 4.8% Advanced Technology Prog. 
2005 13 15.5% Advanced Technology Prog. 
2006 7 8.3% BARDA 
2007 8 9.5% TIP 
2008 5 6.0% Accelerating Cures Act 
2009 16 19.0% SBIR reauthorization 
2010 7 8.3% America Competes reauth. 
2011 14 16.7% SBIR, DoD reauth. 
2012 2 2.4% USDA biomass R&D 
2013 3 3.6% JOBS Act 
    
Total 84 100.0%  
 





Research Objective 4 
Research objective 4 was established to determine the historical research spending 
patterns, by category of research, for the university and industrial sectors.  Table 10 
provides the detail of the descriptive statistics that were calculated from the NSF survey 
data contained in Appendixes B and C.  The table starts with the university sector and 
indicates the mean amount of annual research spending for each research category.  
Included in the table is the range of spending over the 14-year period being investigated 
and the standard deviation for each category.  The final column in the table indicates the 
percentage breakdown of research spending among the categories of research for that 
sector.  For example, 75.8% of the university sector’s total, mean annual spending over 
the period took place in the basic research category.  The percentage spending itemized 
within each sector will add to 100%.  Similar statistics are provided for the industrial 
sector, as well as the statistics for the two sectors’ combined spending.  As expected, the 
results revealed that the percentage spending in the university sector approximated the 
mirror image of the percentage spending in industrial sector. 
Table 10 
 
Descriptive statistics for annual R&D spending, by sector and research category, over 




Mean Minimum Maximum 
Standard 
Deviation 
% of Sector Total 
      
University      
   Basic Research 20,107 13,964 22,788 3,246   75.8 
   Applied Research 5,234 2,642 9,048 1,866   19.7 
   Developmental Research 1,180 637 2,463 575    4.5 






Table 10 (continued).  
Sector/Category 
of Research 
Mean Minimum Maximum 
Standard 
Deviation 
% of Sector Total 
      
Industry      
   Basic Research 8,558 5,673 13,483 2,601   4.1 
   Applied Research 38,141 28,289 45,775 5,188   18.5 
   Developmental Research 159,577 129,328 185,998 15,510    77.4 
      
      
Combined      
   Basic Research 28,665 19,637 35,824 5,101   12.3 
   Applied Research 43,375 32,688 50,998 5,094   18.6 
   Developmental Research 160,757 130,467 186,813 15,650    69.1 
      
 
A graph of the percentage results by research category from Table 10 for both the 
university and industrial sectors, including the trend line linking the research categories 
within each sector are produced in Figures 10 and 11.  By then superimposing these plots 
on top of each other (constructed on the same scale) an empirically derived rendition of 
the standard image of the Valley of Death is produced (refer to Figure 12).   
In the combined graph (Figure 12), the dotted-line columns depict the spending 
for the university sector, and the solid-line columns represent the industrial sector.  The 
dashed trend lines for each sector provide the outline to the shape of the Valley of Death, 
which is presented as the horizontal gap between the trend lines within the applied 
research category.  This result provides direct confirmation of the generalized depictions 
of the Valley of Death contained in the literature (refer to Chapter II).  The shape and 




Figure 10. Historical university sector R&D relative percentage spending patterns, by 
category of research. 
 
Figure 11. Historical industrial sector R&D relative percentage spending patterns, by 





Figure 12. The empirically derived shape of the standard depiction of the Valley of 
Death, based upon sector historical percentage R&D spending patterns. 
 
As can be gleaned from Table 10, the total average annual spending by 
universities has been only a fraction of the total average annual spending by industry over 
the period, namely 12.9% ($26.5B versus $206.3B).  To incorporate the difference 
between the two sectors and appropriately depict this contrast, an adjustment to the 
structure of the graph to reflect the level of absolute spending by each sector is necessary.  
Drawing from the rendition in Figure 12, Figure 13 provides an amended depiction of the 
Valley of Death where the mean annual dollar spending is used for the y-axis, instead of 
relative percentage spending used in Figure 12.  From the revised depiction, what 
becomes immediately apparent is how the industrial sector overwhelms the university 
sector because of the difference in absolute spending.  The other interesting element to 
note is the shift in the point of intersection of the trend lines.  The new depiction indicates 
the Valley of Death is now much flatter and lower than first envisioned.  It has also 
shifted toward the origin, which suggests the Valley of Death originates much earlier in 
the innovation process than the currently perceived mid-stages of development.  




Figure 13.  The empirically derived shape of the Valley of Death based upon historical 
actual average annual R&D dollar spending patterns. 
 
In addition to the adjustment for the absolute level of dollar spending between 
sectors, it is further noted that the university spending total represents the average annual 
spending from all federal grants received.  Many grants, particularly those in the social 
sciences or arts, are likely to yield little commercially viable or patentable knowledge and 
as such, should be excluded from any calculation related to the Valley of Death.  In this 
regard, there has been an average of 14,798 invention disclosures per year throughout the 
period of 1998-2011 (AUTM, 2011), and at an average grant of $397,102, (based on the 
grant award amounts of the National Institutes of Health and the NSF, in constant 2005 
dollars, during the same period), the total amount of federal grants generating university 
invention disclosures was estimated at $5.96 billion annually, representing 22.9% of all 
federal university research grants.  Accordingly, the university sector-spending pattern 
was further adjusted downward to reflect only the R&D spending concerned with 
invention disclosures.  The method of adjustment assumed the same percentage split of 




spending revealed in Table 10.  The resulting adjusted descriptive statistics for estimates 
of university invention related research spending are presented in Table 11.      
Table 11 
 
Descriptive statistics for annual estimated R&D dollar spending attributed to university invention 




Mean Minimum Maximum 
Standard 
Deviation 
% of Total 
      
   Basic Research 4,519 2,500 6,246 1,270   75.8 
   Applied Research 1,176 651 1,626 331   19.7 
   Developmental Research 265 147 367 75    4.5 
      
 
 
The statistics in Table 11 provide the basis for the final rendition of the Valley of Death, 
which solely depicts university invention generating research against industrial R&D 
expenditures.  Figure 14 reflects these results: 
 
Figure 14. The empirically derived shape of the Valley of Death based upon historical 
actual annual R&D dollar spending patterns and limited to university invention 
generating R&D. 
 
The use of the calculations in Table 11 provides the most accurate rendition of the 




commercialization.  Figure 14 was scaled to observe the entire spending patterns of both 
sectors, and it reveals a separation between the two trend lines, commencing in the basic 
research phase of development and continuing throughout the entire development 
spectrum.  For greater clarity on this separation, the y-axis scale was further adjusted and 
Figure 15 provides an expanded view indicating the clear separation in spending from the 
initial position of the trend lines.  
Figure 15. Exploded view of the shape of the Valley of Death in its early stages based 
upon historical actual annual R&D dollar spending patterns and limited to university 
invention generating R&D. 
 
From Figures 14 and 15, it is clear that the level of university research spending 
related to inventions is a small fraction of the R&D activity of industry.  The comparison 
of the trend lines that have been used to historically frame the Valley of Death never 
intersect.  Over the period investigated, they have been independent of each other along 
the spectrum of development, and the currently conceptualized horizontal gap in the 
applied stage of development is not evident.  Instead, a vertical gap between the two 






This chapter presented the results for the research objectives established for this 
study.  Broadly, the purpose of the study was to provide empirical evidence to help 
inform federal policy-making, which is currently focused at mitigating the effects of the 
Valley of Death in university technology transfer.  This purpose was addressed by first 
determining the shared belief held by policy-makers with respect to the cause of the 
Valley of Death.  The results indicated an overwhelming majority of policy-makers 
believed that the Valley of Death was a funding issue associated in the middle stages of 
product development – falling between the results of basic research and final market 
readiness.  Secondly, the historical patterns of R&D spending in the university and 
industrial sectors were derived to provide an empirically based depiction of the Valley of 
Death.  These results showed that when one considers the absolute dollar levels of R&D 
grant funding associated with the development of university inventions then the historical 
model becomes inadequate to describe the Valley of Death phenomenon.  The separation 
between industry and academe is not a function of the stage of development as believed.  
By providing data on current shared beliefs, juxtaposed against the actual historical 
account of the Valley of Death, the appropriateness of federal policy direction can be 
gauged.  The results indicate a disconnection between current causal beliefs and the 





SUMMARY DISCUSSION AND RECOMMENDATIONS 
Summary 
Restatement of Purpose 
The purpose of this study was to expand the current body of knowledge related to 
the Valley of Death in university technology transfer.  The prevailing belief surrounding 
the cause of the Valley of Death is initiating changes to the system of federal research 
grants to universities; however, to date there has been limited empirical work to support 
the causal perceptions related to this phenomenon.  By investigating the beliefs held by 
policy-makers on the Valley of Death and by comparing those beliefs to the historical 
record, appropriate perspective is provided on the direction of current policy-making.   
The Basis for this Investigation, Revisited 
In a globalized knowledge economy, countries today are more compelled than 
ever to have their domestic industries be at the forefront of innovation and technological 
development to drive growth and sustain economic competitiveness (Florida, 2004; 
Porter, 1990).  Consequently, finding ways to effectively increase the rate of 
development of new technologies will enhance national wellbeing (Obama, 2011).  The 
U.S. federal government invests heavily in university research, and capitalizing on that 
research for both societal and economic benefit is a mandate of that funding (National 
Research Council, 2007).  Today, much of the direct economic benefit from university 
research is considered unrealized due to its failure to be fully exploited, with greater than 
90% of all university inventions failing to be adopted by industry (AUTM, 2011).  The 
prevailing understanding is the Valley of Death is an impediment to progress and 




2010).  In order to help contribute to the national policymaking debate on the Valley of 
Death, this study has advanced the body of knowledge and our understanding of the field. 
Results of the Study 
What the study revealed is that 72.6% of the time when the term Valley of Death 
is expressed by politicians and policy-makers, in the context of innovation and 
technology development, it is associated with a funding gap.  In 78.7% of such 
descriptions, the funding needs are specified as being a necessary to support additional 
development work for new technologies as they move from discovery to 
commercialization.  Not surprisingly, the use of the term is more frequent during periods 
of debate on reauthorization of certain federal programming related to technological 
development, for example the SBIR program.     
Other than a capital shortage, additional references to the innovative Valley of 
Death cite general market factors 23.8% of the time to describe the difficulty in 
transitioning technologies from the lab to the market.  Again, in 75% of such descriptions 
the market limiting factors are described as disrupting the process of development at the 
mid-stages of development.  In 3.6% of all references, the Valley of Death is cited 
without specification as to its cause or location.  None of these unspecified references has 
been made since December 2006, which indicates policy-makers may be more informed 
and/or more deliberate in their attempts to contextually frame their point of view on the 
issue.    
In contrast to the beliefs noted above and based on the actual levels of R&D 
spending associated with university inventions, the study has shown the Valley of Death 
is not confined to a funding gap within a defined scope of development activity.  The 




university and industry, have been independent of each other along the entire length of 
the innovation spectrum.  Because the difference in funding between the two sectors 
extends across all stages of development, factors other than stage of development must 
have driven university inventions across the Valley of Death.  This result actually 
supports the prior findings of Auerswald and Branscomb (2003), that the Valley of Death 
is more of a Darwinian Sea of economic survival than a Death Valley drought of funding.  
Under the Auerswald and Branscomb model, the Valley of Death is actually a 
manifestation of the level of market demand by industry for the inventions.  The market 
demand is driven by the availability of information about the invention (Auerswald & 
Branscomb, 2003), and hence, the perceived economic return that an investment in the 
technology would yield to investors (Weston & Brigham, 1975).  More formally, the 
level of market demand is a function of “asymmetries of information” (Auerswald & 
Branscomb, 2003, p. 227) and the risk-adjusted, “expected rate of return” (Weston & 
Brigham, 1975, p. 324) that is then associated with the potential investment.  The 
remainder of this chapter discusses the findings, the limitations of the study, 
recommendations for policy or practice, and suggestions for future research in the field. 
Discussion of Findings 
The key finding of the study is the incongruence between the prevailing belief for 
the cause of the Valley of Death and the historical evidence that indicates the Valley of 
Death goes beyond a simple funding shortfall.  Current beliefs are rooted in the notion of 
a funding gap, located in the middle stages of product development, as having limited 
further development of new technologies.  The idea of an applied research funding 
shortfall originated in the minds of policy-makers in the mid-nineteen nineties through 




ever since (please refer to Figure 1, Chapter II, herein).  The research spending shortfall 
is attributed to the fact the percentage ratio of R&D spending (rounded) among the three 
phases of research in the university sector is 76 (basic) to 20 (applied) to 4 
(developmental), and the same percentage ratio of spending in the industrial sector is 
4:19:77 (refer to final column of Table 10, Chapter IV).  The unbalanced weighting of 
percentage effort at either end of the research spectrum by both sectors relative to the 
middle phase, established the case for an applied research-funding shortfall.   
The study has shown that the ratio of historical spending patterns among the 
phases of research for the combined R&D effort of the university and industrial sectors is   
12:19:69, and of that, the university sector represents only 11.4% of this total (refer to 
Table 10, Chapter IV).  On a combined basis, the evidence indicates there is no unbalance 
in the middle phase of research, only growth from one phase to the next.  This growth 
pattern is to be expected given the foundation of the linear model of innovation, which 
provides the understanding that basic research may lead to many technologies and which 
in turn, may spawn the development of a variety of products, each requiring substantial 
development prior to adoption in the market (Godin, 2006).  Furthermore, when one 
accounts for federal funding solely attributed to invention disclosures at universities, the 
amount of this research relative to combined university and industry R&D spending is 
reduced to only 2.8%, and the overall ratio of spending among the phases of R&D 
becomes 6:19:75.  Again, there is no unbalance in the middle stage of research, only 
growth in spending from one phase to the next.  Since the allocation of funds by industry 
to each phase of research is an economically driven business decision based on potential 
future returns, it is concluded that the choice of a capital investment in university 




investment options, as per the prior findings of Auerswald and Branscomb (2003).  The 
Valley of Death is therefore more accurately characterized as the result of an allocation of 
investment funding, not a shortage of development funding.  The Valley of Death as it is 
conceived by policy-makers is incorrect.  A Valley of Death exists for university 
inventions, but it is simply the final resting place for inventions that fail to satisfy the 
economic criteria of industry.  It is not something to be bridged with additional 
developmental resources.  The lack of development funding for early stage technologies 
is an indicator of their perceived economic viability and not the fundamental cause of an 
interruption in their technological development. 
The appropriately scaled graphical representations of historical spending on 
university inventions and industry innovation reveal the true gap in the patterns of R&D 
spending between the two sectors (refer to Figures 14 and 15, Chapter IV).  In contrast to 
current beliefs and previous depictions, there has been a vertical gap in the level of R&D 
resources employed, not a horizontal gap in the level of development.  This vertical gap 
is present throughout each phase of research and is precipitated by an economic 
allocation of resources.  Therefore, in order to develop a truer representation of the 
Valley of Death, one that is in keeping with the findings of the study, an amendment to 
the parameters of the existing graphical plane is required.  Instead of R&D resources 
plotted against stage of development, the y-axis becomes the market demand for 
university inventions as measured by the expected risk-adjusted rate of return on the 
invention.  The x-axis becomes the universe of all available university inventions, and the 
cumulative distribution function of those expected returns for all those inventions 
becomes the plotted figure.  Along the y-axis, there is a threshold level for the expected 




to industry.  Achievement of this threshold enables the invention to rise out of the Valley 
of Death.  When plotted, the area bounded by the cumulative distribution function at and 
above the threshold level of return represents the proportion of those university 
inventions that satisfy the economic criteria for adoption by industry.  Figure 16 provides 
a generalized depiction of this interpretation of the Valley of Death.  The economically 
feasible range of inventions is depicted by the shaded region.  The Valley of Death is the 
area below the threshold rate of return.    
Figure 16. Revised view of the shape of the Valley of Death based upon expected market 
returns from investments in university inventions. 
 
Note that this revised model also provides a method to conceptually capture the 
work of Auerswald and Branscomb (2003).  Their premise for the level of market 
efficiency associated with university inventions can be theoretically measured under this 
model by directly comparing the number of feasible inventions adopted by industry (i.e., 
the number of university inventions actually licensed to industry) to the total number of 
economically feasible inventions (i.e., the shaded area under the curve in Figure 16).  
This ratio provides a percentage measure of the market efficiency. 
Threshold Rate of 
Return 







Cumulative Distribution Function for 
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Under the proffered interpretation of the Valley of Death, in order to have more 
inventions adopted by industry two options are available for future policy consideration, 
(1) the shape of the cumulative distribution curve will have to be altered and/or (2) the 
threshold rate of return will need to be reduced.  This first option is the target of current 
policy.  Essentially, by amending the nature of the style of university research to more 
application driven R&D, federal policy-makers are estimating that the curve’s shape will 
be altered and a greater proportion of the distribution function will lie above the threshold 
rate.  With respect to the second option, since the threshold rate represents the risk-
adjusted expected rate of return in the marketplace, the threshold level itself cannot be 
directly influenced, but in the case of individual inventions, the threshold rate can be 
directly affected by either increasing the rate of return and/or reducing the risk.  The 
return component is a function of a firm’s potential profitability against the level of 
investment necessary in the invention.  The risk component is a function of the variability 
surrounding the expected returns.  By positively influencing any of the factors driving 
these risk/return elements, the number of inventions that fall above or below the threshold 
rate can be adjusted. 
It is clear that under this model, policy directed at either amending the wholesale 
shape of the distribution function by altering the character of the research (i.e., the 
direction of current policy) or positively influencing the expected rate of return on 
individual inventions, should be able to generate the desired result of enabling more 
university inventions to transfer to industry.  This assumes continuity in the underlying 
distribution, however, any discontinuity in the distribution function would not necessarily 
preclude policies targeted at either approach from working.  A deeper understanding of 




design in those circumstances.  It is this researcher’s opinion that policy directly targeted 
at influencing the level of the expected rates of return on individual inventions, vis-à-vis 
changing the character of university research, would be more effective.  The primary 
rationale behind this position is that this policy approach simply and directly targets the 
parameters governing industry decision-making; it does not substitute different research 
outcomes as the product available to industry.  Secondly, there is no basis to assume that 
any change in the profile of university research outcomes would yield more economically 
feasible inventions, since the choice of the research subject matter is driven by academic 
interests and not market opportunities.  In fact, if changes to the profile of university 
research were to produce more economically feasible outcomes, then university research 
would logically be becoming a substitute for private sector R&D.  Studies to date indicate 
a complementary balance between university and private sector R&D (Diamond, 1998).  
If more substitutive behavior were to occur, then this shift would not only affect the 
academic enterprise (Lee, 1996) but, it may also affect the overall rate of societal growth 
(Feller, 1990). 
One of the assumptions of the study was the applicability of ACF and NPF as 
effective mechanisms for policy change with respect to the issue of technology transfer 
and the commercialization of university research.  Fundamental to the ACF process is its 
contention that policy change is not simply the result of competition among various 
interested parties in which financial resources and institutional control rules the day, but 
where ‘policy-oriented learning’ within and between coalitions is an important aspect of 
policy change.  Policy-oriented learning is a change in thought or intentions resulting 
from experience and/or new information, which is then employed to achieve one’s policy 




for personal beliefs.  First, are deep core beliefs, which are a person’s ontological 
principles and which are highly resistant to change.  Next, are policy core beliefs, which 
are basic normative, ‘party-line’ commitments.  Then, follow an individual’s causal 
perceptions with respect to a particular policy issue.  At any particular time, a coalition 
adopts one or more strategies to prompt policy-oriented learning in an effort to influence 
causal perceptions to change oppositional beliefs and realize its own policy objectives. 
The strategies for policy-oriented learning are usually targeted at lower level 
belief aspects such as causal perceptions, which can be influenced by exogenous 
circumstances (e.g., changes in rules, budgets, personnel, information, etc.).  In the 
circumstances of the Valley of Death, the current change in policy direction is neither a 
deep core nor a policy core change, but the result of a lower level influence – its causal 
perception.  This is evidenced by the unchanging, bi-partisan policy core belief from the 
time of the Bayh-Dole Act of 1980 to today, namely the need for greater translation of 
university research.  Today the difference is the change in the causal perception between 
then (i.e., confounding intellectual property rights) and now (i.e., an applied research 
funding gap).  What is flawed within this ongoing process is the lack of a comprehensive 
understanding of cause and the resulting effect of the proposed change.  The findings of 
the study suggest that new policy-oriented learning will need to take place on two levels.  
On one level, present causal perceptions are currently incorrect; however, amending these 
perceptions will not be as difficult as the additional, potentially needed higher-level 
learning with respect to policy core beliefs that define the purpose of university research.  
Problems for which accepted quantitative data and theory exist are more conducive to 
policy-oriented learning across belief systems (e.g., causal perceptions on the Valley of 




university research).  Assuming stakeholders comprehend impacts of the suggested 
revisions to university research, coalitions will need to be formed based on supporting 
knowledge and strategies developed to debate and expose the social externality issues 
surrounding the proposed policy.       
Threats to Validity and Limitations of the Study 
The study objectives can be divided into two categories, assessment of current 
beliefs and empirical spending evidence.  The approach to each of these categories 
entailed the use of third party data, which brings with it certain cautions due to construct 
and external threats.  With respect to the objectives related to assessment of current 
beliefs, the evidence was drawn from the Congressional Record.  While this source 
provides a verbatim account of Congressional statements as a public record, it may 
influence the statements being made, which is a threat to external validity due to 
interaction of the causal relationship with the setting (Shadish, Cook, & Campbell, 2002).  
In addition, the Congressional Record represents only one source for the data needed to 
generate inferences, which is a threat to construct validity from mono-operation bias 
(Shadish et al., 2002).  Although these threats cannot be overlooked, the overwhelming 
consistency of the use of the term Valley of Death by policy-makers and its uniformity 
with use in the academic literature suggest the findings on the current belief system is 
accurate and pervasive.   
With respect to the objectives related to the historical patterns of R&D spending, 
the main limitation of the study reflects the availability of appropriate data to directly 
relate the level of research spending to the stage of product development achieved.  This 
limitation necessitated the application of the data in each phase of research as discrete 




under the linear model of innovation.  Hence, the trend lines that were derived to describe 
the structure of the R&D patterns of spending and therefore the Valley of Death are not 
the true technology development functions of either industry or academe, but a 
generalized interpretation of their appearance.  More refined data within and across the 
phases of R&D would enable the actual research spending and technology development 
functions to be ascertained, and the true shape of the Valley of Death established.  
Notwithstanding the data limitation, the absolute dollar spending patterns of the two 
sectors provide sufficient evidence that these sectors have not intersected with each other 
in any phase of development over the study period.  Any new information related to the 
amount/pattern of basic university research that produces inventions would have to be 
double the historical experience in order to affect the findings and suggest independence 
has not existed between the sector spending patterns.  The minimal extent of the 
limitations on the findings does not impinge on the conclusion that the existing 
explanation for the Valley of Death is an inappropriate description for this phenomenon. 
Recommendations for Policy and Practice 
In considering recommendations for future federal policy, it is assumed that 
politicians, policy-makers, and the public will continue to seek to mitigate the economic 
consequences of the Valley of Death but do not want to do so at the expense of societal 
growth and overall human capital development.  Under this assumption, it is 
recommended that instead of amending the entire federal university granting system from 
its originally intended purpose, proposed policy should be more targeted.  The granting 
system designed for knowledge creation and disinterested scientific research should 
remain intact, with the requests for funding and the outputs of research being evaluated 




adversely affected.  New knowledge emanating from the research being undertaken that 
appears commercially translational and shows economic promise should be the subject of 
separate grant programs and different evaluation criteria.  Policies that push early stage 
university research further along its development pathway, without considering industrial 
acceptability of the technology, are ignoring market factors.  If basic research is the forte 
of universities and satisfying market demand is the forte of industry then policies focused 
at the intersection of these two would be most appropriate – not a wholesale amendment 
to one end of the process (i.e., the university granting system).  The design of policies 
affecting an entire process that could otherwise be better targeted to a limited subset of 
activity within the process, and without regard to other potential consequences, can be 
likened to using a sledgehammer on a tack. 
Evidence has shown that the U.S. federal government has historically taken the 
position that applied and developmental research should be under the purview of the 
private sectors, with federal focus strictly on basic research, except in certain cases of 
national defense and healthcare (Bush, 1945; H.R. Rep. No. 105-B, 1998).  In the U.S., 
government support for private sector R&D efforts meets with political difficulty, having 
been characterized as corporate welfare (Bozeman, Crow, & Tucker, 1999).  Given the 
political history and the prevailing belief of the cause of the Valley of Death, policy-
makers would appear to have had little alternative up to this point, other than addressing 
the Valley of Death via the university granting process.  However, since it is not 
universities that have their hand on the pulse of the market, any future programming will 
require direct engagement with industry to be most effective.  Precedents do exist for 
U.S. government intervention where markets are not efficient, usually where provision of 




monopolies).  In the case of the Valley of Death, the argument exists for market 
inefficiency that requires federal intervention to capture lost economic opportunity from 
publicly funded research.  The policy narratives should be designed so as not to 
characterize policy as a subsidy to industry but as a mechanism to ensure the maximum 
amount of return is obtained from past and on-going federal investment in university 
R&D.  The understanding of market threshold rates of return provides the basis for 
appropriate policy-oriented learning on the matter.  
As a suggested approach, future policy should directly address market demand 
factors for university technologies.  By implementing a program that can simultaneously 
influence both sides of the Valley of Death, the relevant stakeholders can be drawn 
together.  Essentially, policy should be fashioned to help facilitate universities in the 
dissemination of their research findings without loss of intellectual property rights and 
help support industry through risk mitigating programs, enabling greater adoption of 
early stage technologies.  This policy approach may well require additional investment in 
applied development, but this would not be development for development’s sake.  It is 
funding, which will lower ultimate development costs, that will yield additional evidence 
of profitability and firm-up market competitiveness of the invention.  The new 
information generated will determine the extent of commercial feasibility and hence 
potential economic return to industry.  The effect is to de-risk the invention in the eyes of 
industry.  This effectively causes upward movement on the expected rate of return above 
the threshold level and hence increased attractiveness to industry. 
Illustrations of where such joint policies exist may be found in other jurisdictions.  
For example, the Canadian national scientific granting council, the Natural Sciences and 




Research and Development Grant (CRDG).  CRDGs support well-defined projects 
undertaken by university researchers in conjunction with private-sector partners.  The 
industrial partner and the federal agency share direct project costs.  Projects can be at any 
point in the R&D spectrum, and the industrial partner must contribute to the direct project 
costs in an amount equal to or greater than the amount requested from NSERC.  The 
industrial partner’s cash contribution must be at least half of the NSERC request, while 
the balance can be provided as in-kind contributions.  The key difference between this 
program and any in the U.S. is the projects are initiated by industry and hence already 
have a market driven focus.  By targeting such a program to involve U.S. university 
inventions, industry has the potential to cut development costs in half, thereby enhancing 
economic feasibility.  Adoption of university expertise, strategic alignment of inventors 
with commercial partners, additional capital resources, and a clearly identified path to 
market for university inventions would be the result.  
 A further example of government – industry collaboration in applied technology 
development recently emerged when the European Commission announced in July 2013 
that the European Union (EU) and European industry would jointly invest more than €22 
billion over the next seven years in innovation.  The program entails an €8 billion 
investment from the Commission’s existing innovation program, Horizon 2020, €10 
billion from industry and a further €4 billion from EU Member States.  Funds are to be 
invested in five areas of Public-Private Partnerships, called Joint Technology Initiatives 
in the fields of innovative medicines, clean energy, clean air transport, bio-based 
industries, and electronics.  In support of the program the President of the European 




that provide high quality jobs.  This innovation investment package combines public and 
private funding to do just that " (Barroso, 2013, para. 2). 
In similar fashion to the Canadian and European situations, the proposed policy 
recommendations would leverage the resources and capabilities of the public, academic, 
and private sectors for national benefit and growth.    
Recommendations for Future Research 
Given the revised understanding of the Valley of Death as indicated by the 
findings, this study suggests additional research takes place on three fronts: (1) seeks to 
determine the distribution of spending within the stages of development for both the 
academic and industrial sectors; (2) investigate the impact of a movement in the focus of 
university grants to more applied areas of research and; (3) analyses the risk/return 
factors associated with the threshold rate of return underpinning the market demand for 
university inventions.  Additional research recommendation (1) will enable the derivation 
of a continuous production function for the linear model of innovation and thereby 
further refine the findings of the study.  Additional research recommendation (2) will act 
as a predictor of any change in the demand for university inventions by industry and will 
enable a more accurate depiction of the generalized cumulative distribution curve of 
expected rates of return on university inventions.  As well, this additional research will 
provide a confirmation of R&D spending behavior by industry, that is, whether or not 
more applied university research will act as a complement or a substitute for industrial 
R&D and thereby identify potential economic consequences of universities taking on 
more applied research.  This will serve to provide additional quantitative data to support 
policy-oriented learning regarding the purpose and effectiveness of university research.  




underlying parameters surrounding market acceptance of university inventions and will 
help provide a framework for market based policy strategies to positively influence the 
adoption of university inventions. 
Conclusion 
The study has altered the perception Valley of Death in the mind’s eye of this 
researcher and has provided evidence about how its basis differs from the way it is 
perceived by policy-makers.  A Valley of Death exists for university inventions, but it is 
the final resting place for inventions that fail to satisfy the economic criteria of industry.  
It is not something to be simply bridged with additional development resources.  The lack 
of development funding for early stage technologies is an indicator of their estimated 
economic potential and not the fundamental cause of an interruption in their 
technological development.  The failure of the transfer of university inventions to the 
industrial sector is therefore more accurately characterized as the product of an economic 
allocation of private sector investment funding, not a gap in available research funding. 
Because the study found that the causal perception of the Valley of Death is not 
consistent with the historical evidence, the foundation of current policy direction is 
brought into question.  Today the consensus policy strategy is to shift the emphasis from 
basic research to more applied programming in the hopes of making more university 
research economically attractive.  The problem with this approach is that it fails to 
consider any other ramifications associated with the policy change.  Referring back to the 
conceptual framework in Chapter I (Figure 1) and the discussion of the theoretical 
precepts underpinning its structure, it was observed that the dissemination of new 
university knowledge has both economic development as well as human capital 




strategic vehicle for economic development over its historical and primary human capital 
development mission is a fundamental change in governing philosophy.  This policy 
direction places the production of commercializable knowledge, solely with economic 
benefit, ahead of the generation of disinterested scientific knowledge that potentially 
contains greater and broader societal benefit.  Not only does this focus have ramifications 
on the mission and internal operation of universities, but without a holistic appreciation 
of the situation, such a narrowly constructed policy direction can create negative 
externalities that could go well beyond any stand-alone, desired economic benefits.  The 
fear expressed by many academicians in the 1990s (Lee, 1996) about this academic 
evolution should now be a center point of discussion, but it is not even being mentioned 
let alone debated in the current policy narratives surrounding the advocacy for change.        
Although the study set out to advance our understanding of the Valley of Death, it 
has added specific focus to the literature by offering empirical support to the prior work 
of Auerswald and Branscomb (2003) and their concept of survival of the fittest 
technologies in a Darwinian Sea of economic competition.  In addition and perhaps most 
importantly, it has created a case for university technology transfer to be studied more 
deeply as an interdisciplinary issue.  In this regard, there needs to be particular emphasis 
on the human capital development implications of proposed policy change.  Rather than 
policy being driven by narrow objectives based on an outdated understanding, the study 
has revealed that the technology transfer process should receive the full benefit of a 
comprehensive interdisciplinary examination if we are to gain a true cognitive 
appreciation of its political, societal and economic influences.  Just as the ‘butterfly 




transfer policies within the specific framework of only one discipline (i.e., economic 






DESCRIPTION AND BACKGROUND ANALYSIS OF UNIVERSITY 
TECHNOLOGY TRANSFER 
This appendix seeks to provide additional background and detail on the 
technology transfer process depicted in the conceptual framework of Chapter I (refer to 
Figure 1).  It also includes an analysis of the key operating parameters across and within 
TTOs.   
The meaning of technology-transfer utilized in this study is narrower than 
standard definitions of technology transfer, in that only one mechanism of technology 
transfer is considered (i.e., inventions).  At the same time the examination is further 
restricted to the university situation.  By comparison, the on-line dictionary, 
Dictionary.com, defines technology transfer as “the movement of new technology from 
its creator or researcher to a user, esp. as products or publications; also, the movement of 
new technology from developed areas to less-developed areas” (Dictionary.com, 2012).  
From a more academically inclined viewpoint,  Abramson et al. defines technology 
transfer as “the movement of technological and technology-related organizational know-
how among partners (individuals, institutions, and enterprises) in order to enhance at least 
one partner’s knowledge and expertise and strengthen each partner’s competitive 
position” (Abramson et al., 1997, p. 2).  In contrast, the definition adopted here is the 
dissemination of new knowledge captured in the form of inventions, which have been 
discovered by university researchers.    
The typical operating process for university TTOs, starts when an invention 
disclosure is received from a faculty researcher (Siegel, Waldman, & Link, 2003).  The 




a technical, patentable and commercializable standpoint.  After this initial review, and if 
the invention is deemed to have merit, TTO staffers will then seek to commercialize it in 
some fashion, usually by licensing the rights for the technology to the private sector 
(Graff et al., 2002).  In the process, TTOs will seek to protect the intellectual property, 
usually by filing a patent application.  If fortunate, the patent office will issue a patent 
providing a series of claims that will be of interest and value to industry.  In parallel 
manner to the industrial linear model of innovation, the technology transfer process can 
be depicted as a sequential series of steps.  An example of a successful technology 
transfer process can be illustrated as follows:   
Invention Disclosure  TTO Assessment  Patent Application  Patent Issues  
License Agreement with Industry  Income Stream to University 
Similar to the criticism of the industrial linear model of innovation, as noted in 
Chapter I, the linear process indicated above might not necessarily follow this sequential 
pattern in all cases.  For example, certain technologies may not be suitable for patenting, 
or may never issue as a patent and they may be licensed as a trade secret.  Additionally, 
given the cost and timing associated with the commercialization/patenting process, TTOs 
are typically attempting to license technologies to industry at any opportune point and in 
many cases ahead of the actual issuance of a patent.  Generally, TTOs would also seek to 
include reimbursement of patent costs within the license agreement (Ferguson, 2011).  
Since 1991, the historical operating data from each of the various steps within the 
technology transfer process outlined above have been collected in annual surveys of its 
members by AUTM.  This is the largest single source of information on the subject 
matter.  These surveys have grown in both scope and depth over the period.  Today over 




data, various operating results for TTOs have emerged to be suitable performance 
measures for growth and comparison purposes, most notably: numbers of invention 
disclosures, patent applications, patents issued, licenses executed and license income.  
Other data collected includes such items as R&D funding, staffing levels, budgets, age of 
office, etc. (AUTM, 2011).   
The AUTM data offers the means for an industry wide analysis across all TTOs, 
as well as the opportunity to conduct comparative analysis among separate TTOs.  In this 
Appendix, both these approaches have been undertaken to provide additional perspective 
on the operations and effectiveness of TTOs.   
Industry Wide TTO Performance Metrics 
 Data drawn from the most recent five years of AUTM surveys has been 
accumulated in Table A.  This data reveals that the ratio of initial invention disclosures to 
patent applications to approved patents to industry licensing contracts is:  6.2 : 3.0 : 1.2 : 
1 (AUTM, 2011).  That is to say, for every 6.2 invention disclosures, 3.0 patent 
applications are filed, which results in 1.2 patents being granted and one licensing 
contract being executed.  It should be noted that this is aggregate data and no allowance 
has been built into the analysis to provide for lead/lag effects.  In this regard, the receipt 
of an invention disclosure initiates a review process, which may lead to a patent 
application (which may also be preceded by a provisional patent filing which potentially 
allows a further 12 months prior to the patent filing).  Once a patent application is filed, 
the average time to issue is currently running 3 years (USPTO).  In addition, a license 
agreement may be executed at any time after the invention has been disclosed.  No timing 
adjustments were made in this instance, as the purpose is not to match one sequential 




process.  The reader is referred to Mowery et al. (2004)for a full discussion and historical 
account of technology transfer and its performance metrics.   
Table A 
Five Year Combined Operating Performance of U.S. University TTOs for the five year 

















      
Aggregate Data $ 161,326 91,901 43,832 17,626 14,761 
Conversion Rate 
$1.8 per invention 
disclosure 
100.0 47.7 19.2 16.1 
Success Rate    40.2% 83.7% 
Ratio to Licenses 
Executed 
 6.2 3.0 1.2 1.0 
      
  
Given the data in Table A, on the surface it would appear that the least effective 
stage in the university commercialization process lays in the difference between the 
number of patents filed and the number of patents issued.  This is represented by a 
success rate of 40.2% (ratio of 1.2 patent approvals for every 3.0 patent applications).  
This apparent low success ratio has created a perception that the university technology-
transfer process is inefficient when cited against a forty-year average historical success 
rate of 65% at the US Patent and Trademark Office (Landes & Posner, 2003).  When 
being compared to industry’s success rate, it should also be noted that universities, when 
moving from an invention disclosure to deciding on a patent application, typically have 
less than a month to determine if they wish to protect the intellectual property being 
disclosed.  For example, there were 19,732 invention disclosures in 2011 that were 




disclosure per licensing officer every 9.4 working days.  The decision process to 
determine whether to commercialize/patent or not entails a technical and scientific 
assessment, reviewed against the existing literature and patent landscape; a potential 
market analysis; and then development of a commercialization strategy which emerges 
from the market analysis.  Industry has the capability to more fully develop their 
technologies before considering final commercial feasibility and if a need for patent 
protection exists.  On average it takes 7 years within industry between the research 
finding and the first introduction of a commercial product (Mansfield, 1991, 1998). 
What the foregoing information reveals is an affirmation of the characteristic trait and 
need for universities to file patent protection at the very earliest stages of the innovation 
process and usually on short notice.  One of the primary reasons for proceeding to patent 
at such an early stage reflects the need for the university researcher to publish his/her 
results.  Publication of research results is a bar to future patent protection under current 
patent laws (12-month grace period in the U.S. only; complete bar under the international 
Patent Convention Treaty) and accordingly patenting decisions must be made in an 
expeditious fashion vis-à-vis a publication deadlines.  In addition, the governing act for 
technology transfer of federally funded R&D (Bayh-Dole) requires that if any future 
commercialization is sought, the technology needs to be protected via patent.  It is also 
highly likely that additional external resources will be required to develop the technology 
further.  In this regard, the intellectual property needs to be protected before disclosing to 
potential strategic partners/financiers.  Considering the regulatory directives on patenting, 
the early-stage nature of the technologies, the timing pressures on TTOs, the need for 
external resources for additional development, the potential opportunity cost of lost 




(potentially responsible for lost income to the inventor), one would expect to see a higher 
level of patenting activity by universities than industry.   
In analyzing the performance of TTOs, it should be noted that the license income 
they receive represents only a small fraction of the commercial worth of the technology.  
University license agreements are usually structured such that payments to the university 
are in a form of a royalty on gross sales of the technology by the licensee.  In 2011, U.S. 
universities produced $2 billion dollars in license revenue and taking an average 3% 
royalty-rate on net sales (Stevens & Phil, 2003), the total direct sales of products and 
services derived from university technologies would approximate $70 billion.  In the 
same year, the federal government spent $30 billion on university R&D, thereby yielding 
an annual rate of return of 233% on their investment.  This industry-wide analysis of 
TTOs serves to demonstrate that universities appear fully capable of technology transfer 
however; the prevailing structure for the protection of intellectual property would not 
appear to be congruent with the nature of their business or the stage of development of 
their technologies.   
Complementing the foregoing industry-wide analysis, the following analysis 
focuses on aspects of potential differential performance among TTOs to ascertain if there 
are potential individual TTO ‘best practices’ that could be more widely adopted to 
enhance overall technology transfer performance.     
TTO Comparative Analysis - Commercialization Best Practices   
While the previous section revealed positive performance statistics for university 
commercialization activity as a whole, only a few select universities appear to be able to 
create an economic success out of their technology transfer activity.  In fact, only 16% of 




not the Valley of Death could be mitigated or even removed if the remainder of the TTOs 
adopted the best practices of the top few.  Underlying this question is the basic 
assumption that the top performing universities possess greater capability in some 
aspect(s) of the technology-transfer process over and above their counterparts.  
Accordingly, these top performers should produce performance metrics around certain 
operating parameters that differentiates them from their peers.  This assumption was 
actually analyzed statistically in the literature by Ferguson (2011).  Within this work he 
tested the hypothesis that the top-ten license income producing TTOs are better operating 
performers than their colleagues as indicated by differences in the key TTO standard 
operating metrics:  (1) number of invention disclosures received, (2) number of patent 
applications filed, (3) number of patents granted and (4) number of active licenses with 
industry. 
In testing this hypothesis, Ferguson conducted independent t-tests between two 
defined groups of TTOs to determine if there is a difference in their modus operandi.  
The analysis consisted of two subdivisions of non-equivalent groups: the first group 
being the top-ten license income producing U.S. university TTOs (taken from a direct 
ranking of total gross licensing income for all TTOs in the AUTM database over the 
period 1996 through 2008) and the second group consisting of all other AUTM survey 
responding U.S. universities over the same period.  The dependent variables consisted of 
the four key operating parameters of TTOs, namely: number of invention disclosures 
received, number of patent applications filed, number of patents issued and number of 
active licenses with industry.  This hypothesis was tested twice.  The first time as noted 




variables had been factored to reflect the level of federally funded R&D taking place at 
the university.  
The results of the first tests revealed that across all tested TTO operating 
parameters, the top-ten licensing universities in the country performed significantly better 
than their colleagues did.  However, when one controls these operating parameters based 
on the dollar level of federal R&D received by the institution (e.g., number of invention 
disclosures per dollar of research funding received), it turns out that there are no 
statistical differences among any of the operating metrics of the top-ten universities vis-a-
vis their peers.  In fact, they underperform against their colleagues on all of these same 
operating measures with the performance metrics falling below the mean in each case.  
The consequence of these findings being, that whatever technology transfer practices are 
being employed, they appear to be systematically employed by all TTOs.  There are no 
distinguishing “best practices” displayed within the operating metrics of the top-ten 
universities, which can be leveraged to enhance performance and economic impact 
(Ferguson, 2011). 
From the same study by Ferguson it was observed that a positive correlation 
existing between the level of annual federal R&D spending and the amount of license 
income generated, with a Pearson r correlation calculated at .30 (p <.001) (Ferguson, 
2011).  While statistically significant, the low power of these findings suggests other 
variables are at play.  Combining this fact with the understanding that there is no 
significant difference in the operating parameters between highly successful revenue 
generating TTOs and less successful TTOs, then the conclusion was reached that 
unidentified systemic factors must be influencing the lack of commercial licensing of 





FEDERALLY FUNDED R&D AT U.S. UNIVERSITIES BY CLASSIFICATION OF 
RESEARCH FOR THE PERIOD 1953 THROUGH 2011 
(INFLATION ADJUSTED 2005 CONSTANT DOLLARS) 
Year Basic Applied Development Total 
1998 13,964 2,642 1,139 17,745 
1999 14,858 3,067 819 18,744 
2000 15,741 3,603 637 19,981 
2001 17,143 3,921 742 21,806 
2002 19,224 4,349 718 24,291 
2003 20,883 4,837 975 26,695 
2004 21,853 4,940 1,278 28,071 
2005 22,186 4,900 1,168 28,254 
2006 21,979 5,014 915 27,908 
2007 21,692 5,079 860 27,631 
2008 21,643 5,507 793 27,943 
2009 22,093 5,994 689 28,776 
2010 22,073 8,504 2,364 32,941 
2011 22,637 9,048 2,463 34,148 
 
Source: National Science Foundation, National Center for Science and Engineering 






U.S. INDUSTRIAL R&D EXPENDITURES BY CLASSIFICATION OF RESEARCH 
FOR THE PERIOD 1953 THROUGH 2011  
(INFLATION ADJUSTED 2005 CONSTANT DOLLARS) 
 
Year Basic Applied Development Total 
1998         5,673        34,587        129,328        169,588  
1999         6,381        38,978        140,876        186,235  
2000         6,892        41,133        158,060        206,085  
2001         8,045        44,539        151,454        204,038  
2002         7,223        28,289        156,977        192,489  
2003         7,377        34,908        152,038        194,323  
2004         6,988        42,007        145,284        194,279  
2005         7,559        39,995        156,696        204,250  
2006         6,723        43,623        166,028        216,374  
2007         7,990        45,775        174,692        228,457  
2008       10,032        38,189        185,998        234,219  
2009       12,252        30,309        178,729        221,290  
2010       13,483       36,220       170,835 220,538 




Source: National Science Foundation, National Center for Science and Engineering 






CALCULATION OF FEDERAL GRANTS ATTIBUTED TO INVENTION 
DISCLOSURES RECEIVED BY TECHNOLOGY TRANSFER OFFICES 
 
 


























1998  27,058   7,985   9,337   345,077   9,555   3,297  
1999  28,928   8,640   9,958   344,248   10,052   3,460  
2000  31,266   9,996   11,266   360,336   10,701   3,856  
2001  33,173   11,199   12,344   372,107   11,259   4,190  
2002  35,865   12,679   13,752   383,434   12,638   4,846  
2003  37,875   14,416   15,314   404,334   13,718   5,547  
2004  37,069   15,322   15,831   427,072   15,002   6,407  
2005  36,998   15,818   15,818   427,526   15,371   6,571  
2006  36,890   15,660   15,169   411,208   16,855   6,931  
2007  37,091   16,068   15,126   407,815   17,677   7,209  
2008  36,422   16,079   14,808   406,571   17,694   7,194  
2009  35,664   16,579   15,110   423,664   18,163   7,695  
2010  35,546   16,954   15,275   429,732   18,635   8,008  
2011  35,250   16,685   14,719   417,562   19,732   8,239  
Mean    34,650     13,863    13,845     397,102      14,789       5,961  
Standard 
Deviation 






CODING RESULTS FOR THE DIMENSIONS OF THE VALLEY OF DEATH 
 























































































3/21/1991        
4/30/1991        
6/25/1992        
8/10/1992        
11/20/1993        
5/26/1994        
4/18/1996        
9/29/1997        
3/7/2001 1    1  1 
7/20/2001 3 1  2 3  1 
9/10/2001 1    2  1 
9/24/2001 6 3   4  2 
2/25/2004 5 4   9  4 
4/7/2004        
5/19/2005        
6/9/2005 3    3  1 
7/29/2005 2 1   1  2 
9/14/2005 (1) 2 1     1 
9/14/2005 (2) 1   2 1  1 
10/21/2005 3   1 1  2 
11/18/2005        
12/14/2005 (1) 1 4 3 1   1 
12/14/2005 (2) 1 1  1   1 
12/14/2005 (3) 2 3  1   2 
12/14/2005 (4) 5 1  1   1 
2/15/2006    1   1 

























































































9/26/2006 (1)  3     1 
9/26/2006 (2) 2 2     2 
12/5/2006        
12/27/2006 2 2     1 
1/4/2007    1 2  2 
1/17/2007  1     1 
5/3/2007  1  3 7  2 
8/2/2007 (1)  1     1 
8/2/2007 (2) 4      1 
9/27/2007    1   1 
12/11/2007        
12/19/2007        
4/30/2008     2  1 
5/7/2008 (1) 3 4  1 1  1 
5/7/2008 (2) 7 2  1 1  2 
7/8/2008    1 4  1 
8/1/2008        
11/20/2008        
4/27/2009        
4/28/2009 2      1 
5/6/2009      (a) 1 
7/8/2009 (1) 1 1   3  1 
7/8/2009 (2) 3      1 
7/8/2009 (3) 2      1 
7/13/2009     3  1 
9/16/2009 1 1   2  1 
10/20/2009 (1) 2   1   1 
10/20/2009 (2) 2    5  4 
10/20/2009 (3)     1  3 
10/30/2009    1 1  1 
11/18/2009   1    1 


























































































12/15/2009   2    1 
3/19/2010  1     2 
5/12/2010 (1)  1   1  1 
5/12/2010 (2) 1 2 1  1  1 
5/12/2010 (3)      (a) 1 
9/29/2010        
12/8/2010        
12/9/2010        
12/21/2010 4    1  2 
1/7/2011        
2/2/2011      (a) 3 
3/15/2011 (1)    1 1  2 
3/15/2011 (2)    1   1 
3/15/2011 (3)     2  1 
5/27/2011  1   1  1 
7/14/2011 3 3 1  3  4 
8/1/2011        
11/2/2011        
11/4/2011        
11/10/2011        
12/6/2011 1 1     1 
3/12/2012        
6/14/2012 1 2 1  1  2 
6/21/2012        
1/23/2013        
3/6/2013        
5/15/2013    1   1 
8/2/2013        
10/31/2013 1   1   1 
11/13/2013    1 1  1 
Count 78 48 9 26 74 58 84 








CHRONOLOGICAL LISTING OF CONGRESSION RECORDS CONTAINING THE 
TERM VALLEY OF DEATH 
Congressional       Number of 
     Session     Date    Occurrences                Context 
102  3/21/1991  1  Other 
102  4/30/1991  1  Other 
102  6/25/1992  1  Other 
102  8/10/1992  1  Other  
103  11/20/1993  1  Other 
103  5/26/1994  1  Other 
104  4/18/1996  1  Other 
106  9/29/1997  1  Other 
107  3/7/2001  1  Innovation 
107  7/20/2001  1  Innovation 
107  9/10/2001  1  Innovation 
107  9/24/2001  2  Innovation 
109  2/25/2004  4  Innovation 
109  4/7/2004  1  Other 
109  5/19/2005  1  Other 
109  6/9/2005  1  Innovation 
109  7/29/2005  2  Innovation 
109  9/14/2005  2  Innovation 
109  10/21/2005  2  Innovation 
109  11/18/2005  2  Other 
109  12/14/2005  6  Innovation 
109  2/15/2006  1  Innovation 
109  5/4/2006  2  Innovation 
109  9/26/2006  3  Innovation 
109  12/5/2006  1  Other 
109  12/27/2006  1  Innovation 
110  1/4/2007  2  Innovation 
110  1/17/2007  1  Innovation 
110  5/3/2007  2  Innovation 
110  8/2/2007  2  Innovation 
110  9/27/2007  1  Innovation 
110  12/11/2007  1  Other 
110  12/19/2007  1  Other 
110  4/30/2008  1  Innovation 
110  5/7/2008  3  Innovation 
110  7/8/2008  1  Innovation 
110  8/1/2008  1  Other 




CHRONOLOGICAL LISTING OF CONGRESSION RECORDS CONTAINING THE 
TERM VALLEY OF DEATH 
Congressional       Number of 
     Session     Date    Occurrences                 Context  
 
111  4/27/2009  1  Other 
111  4/28/2009  1  Innovation 
111  5/6/2009  1  Innovation 
111  7/8/2009  3  Innovation 
111  7/13/2009  1  Innovation 
111  9/16/2009  1  Innovation 
111  10/20/2009  6  Innovation 
111  10/30/2009  1  Innovation 
111  11/18/2009  1  Innovation 
111  12/15/2009  1  Innovation 
111  3/19/2010  2  Innovation 
111  5/12/2010  3  Innovation 
111  9/29/2010  2  Other 
111  12/8/2010  1  Other 
111  12/9/2010  1  Other 
111  12/21/2010  2  Innovation 
112  1/7/2011  1  Other 
112  2/2/2011  3  Innovation 
112  3/15/2011  4  Innovation 
112  5/27/2011  2  Innovation 
112  7/14/2011  4  Innovation 
112  8/1/2011  1  Other 
112  11/2/2011  1  Other 
112  11/4/2011  1  Other 
112  11/10/2011  1  Other 
112  12/6/2011  1  Innovation 
112  3/12/2012  2  Other 
112  6/14/2012  2  Innovation 
112  6/21/2012  1  Other 
113  1/23/2013  1  Other 
113  3/6/2013  1  Other 
113  5/15/2013  1  Innovation 
113  8/2/2013  1  Other 
113  10/31/2013  1  Innovation 






CITINGS AND CODING OF CONGRESSION RECORDS CONTAINING 
THE TERM ‘VALLEY OF DEATH’ RELATED TO INNOVATION 
CONGRESSIONAL RECORD—Extensions of Remarks March 7, 2001; p. E294 
And that problem-solving ethos has been maintained to this very day—whether 
NIST is probing abstruse questions about the molecular structure of ceramics, or 
helping to ensure the security of our computers, or providing guidance to a small 
manufacturer on how to update his operations through the Manufacturing Extension 
Program.  And we also still draw on NIST’s expertise to solve problems that are 
endemic to the economy as a whole—with the Advanced Technology Program, for 
example, which has helped a wide variety of companies pass through the so-called 
‘‘valley of death’’ that can prevent good research ideas from becoming good 
processes or products.  
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Unspecified cause, Location Described 
 
CONGRESSIONAL RECORD—Extensions of Remarks July 20, 2001 
The Advanced Technology Program is not public financing of established 
technologies. It should not be seen as speculative investment nor should its success 
be measured in the same economic terms as private investment. Framing the debate 
in these terms is  fundamentally wrong and misses the point of the program. The 
ATP is a research and development program, not an exercise in government venture 
capital. The program seeks to provide a critical bridge for the funding gap from 
innovation to the marketplace of pre-competitive, emerging technologies. ATP 
seeks to smooth the transition from invention to commercialization, the so-called 
valley of death or Darwinian Sea. The United States has the greatest research effort 
in the world. Our universities and industries develop more ideas and discover more 
innovations than everywhere else combined. We also understand capital markets 
and have used our knowledge to produce the world’s most vibrant and robust 
economy. Yet we are still not very good at turning raw ideas into commercial 
products. While it is tempting to believe that this process is straightforward and 
should be understandable from basic social and economic principles, it is not and 
cannot. The relationship between the private sector and this intermediate stage 
between research and venture capital investment is poorly understood and the 
subject of intense scrutiny. It would be wrong to treat it as a mature, fully-formed, 
capital arena. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 




CONGRESSIONAL RECORD—SENATE September 10, 2001 
Is ATP a success? The answer clearly is yes. The Advanced Technology Program 
has been extensively reviewed.  Since its inception, there have been 52 studies on 
the efficacy and merits of the program. These assessments reveal that the ATP does 
not fund projects that otherwise would have been financed in the private sector.  
Rather, the ATP facilitates so-called Valley of Death projects that private capital 
markets are unable to fund. In June 2001, the National Academy of Sciences’ 
National Research Council completed its comprehensive review of the ATP. It 
found that the ATP is an effective Federal partnership that is funding new 
technologies that can contribute to important societal goals. They also found that 
the ATP could use more funding effectively and efficiently. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Unspecified location 
 
CONGRESSIONAL RECORD—HOUSE September 24, 2001 
Approximately 5 years ago, I was chartered by then-Speaker Gingrich and the 
gentleman from Wisconsin (Mr. SENSENBRENNER), the chairman of the 
Committee on Science and Technology, to prepare a report on updating the science 
policy of our Nation and outline where we should be heading. That report came out 
of the Committee on Science and Technology, was approved by the House of 
Representatives, and became popular enough that it is now in paperback. In that 
report, we made a major statement on several issues; one of which was to bridge the 
so-called valley of death between basic research and applied research so that we 
could have more ideas flowing out of basic research into applied research and 
eventually into product development. The program we are talking about here today 
is a program which can help bridge that valley. We are recommending,  based on 
the success of this program, that it be reauthorized and, in fact, improved. 
Investment in technology, research, and development and this scientific enterprise 
is a key component of sustaining the economic growth of the past decade, much of 
which is based on developments in science and technology. As growth slows, 
Congress must seek ways to bolster its investment and renew strong economic 
performance. I am pleased to rise in support of this legislation because it will bring 
research out of the labs and into the marketplace to help our economic engine roar 
back to life.  
Occurrences of ‘Valley of Death’: 2, (1 repetition) 
Coding: Funding gap, Location Described 
CONGRESSIONAL RECORD—SENATE February 25, 2004 
In discussing the need for a Government role, a basic principle with which nearly 
everyone would agree is that a Government role makes sense when there is a 
market failure of some sort. When it comes to advanced technology, there is ample 




basic research ends and the point at which private capital market support of product 
development begins.  Now, let me try to illustrate that by referencing this chart. 
This chart is called the ‘‘Valley of Death’’ just to try to wake up my colleagues to 
the fact that this is an important issue.  Here, looking at this vertical axis, we are 
showing the invested money. Along the horizontal axis, we are showing the various 
stages of developing a technology-  based product for use. The Government does 
invest a fair amount of money in basic research. That is shown over here at the left, 
in the beginning stages of developing a product or developing a technology.  Here 
we show labs and universities … Industry invests most of its research and 
development dollars at the other end of this development continuum and invests 
those funds on commercializing short-term, low-risk, reliably profitable products, 
and then making incremental improvements on those products which they are fairly 
confident they can make a return on in the market. In between these two stages of 
the research and development process, we have what many in the industry call the 
Valley of Death. That is the gap where our private capital markets fail to invest 
applied research dollars to create pre-product, so-called platform technologies. This 
market failure occurs because such generic technologies are too expensive or they 
are too risky for industry to develop on its own … But for technologies with 
predominantly civilian applications, the Federal Government does not have the 
strong customer stake in developing specific technologies. So filling in this funding 
gap in the Valley of Death is precisely the role that the Advanced Technology 
Program plays for civilian technology … Let me give a few examples of actual 
ways in which the Advanced Technology Program has succeeded in bridging the 
‘‘Valley of Death’’ for U.S. industries with a resulting positive impact on our 
economy and our global competitiveness. In 1991, the Council on Competitiveness 
characterized the U.S. printed wiring board industry as losing badly or lost. That 
was their description. By this they meant the U.S. was not likely to have a presence 
in that industry within 5 years. It attracted little private venture funding. 
Occurrences of ‘Valley of Death’: 4 (3 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—SENATE June 9, 2005 
These parks are the result of a number of carefully crafted government policies and 
incentives dealing with taxes, real estate, and fundamental research. In the area of 
technology transfer, the Taiwan government helped set up the world famous 
Industrial Technology Research Institute (ITRI) which has over 5,000 scientists 
working to spin out laboratory ideas across the valley of death into new industries. 
Remarkably, the two chip foundry companies which now control 70 percent of the 
world’s foundry market were launched from ITRI. As a result of this rapid 
economic growth, Taiwan’s technical universities are now world class with their 
own excellent graduate programs. The reason they are side-by-side with these large 
science parks is to supply a steady stream of talented researchers. 




Coding: Unspecified cause, Location Described 
 
CONGRESSIONAL RECORD—SENATE July 29, 2005 
This science park, like the others I visited in Asia, teams up with the local 
universities on collaborative research efforts. It has an incubation center with 83 
start-up companies, and provides them low cost space, business planning, 
marketing, and employee training, as well as research and development grants from 
the Hong Kong Government to overcome the valley of death challenges so many 
new technology companies frequently face ...  Additionally, the legislation proposes 
a Science Park Venture Capital Fund similar to SBIC’s, that would guarantee 
debentures issued by the Fund to raise capital for start-up companies trying to 
bridge that valley of death, where ideas must move from the  laboratory to working 
prototype. 
Occurrences of ‘Valley of Death’: 2 (1 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—SENATE September 14, 2005 
How does this agency work? ATP funds development in technology that is too new 
or too risky for private sector investment in the so-called valley of death between 
research and commercialization. There is lots of money around for research and 
there is money around for commercialization but not for that bridge between those. 
ATP fills this gap. It does not displace private capital because these projects cannot 
get private capital.  
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
The Advanced Technology Program fills a unique role in U.S. innovation policy. 
ATP bridges the gap, the so-called valley of death between innovative ideas arising 
from basic research in the laboratory, and the access to market capital to 
commercialize them. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
 
CONGRESSIONAL RECORD—SENATE October 21, 2005 
However, many times innovative research becomes victim of the Valley of Death 
by failing to advance from the research labs to application in commercial products 
and services … My bill is aimed at narrowing this so called Valley of Death, by 
focusing on bringing research to commercialization.  To reach this objective, my 




entities with experience in micro- and nanotechnology and for each institute to 
develop and maintain business plans. 
Occurrences of ‘Valley of Death’: 2 (1 repetitions) 
Coding: Development gap, Location Described 
 
CONGRESSIONAL RECORD—SENATE December 14, 2005 
Cures promotes the innovative efforts of small to medium sized biotechnology and 
bioengineering firms who require additional support in key traditionally under-
funded stages of product development—the so called R&D Valley of Death.  It 
expands the NIH’s current small business support and rapid access to interventional 
development programs to move basic science through the product development 
pipeline faster. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
Promote the innovative efforts of small to medium sized biotechnology and 
bioengineering firms. The ACC will support firms requiring assistance in key 
traditionally underfunded stages of research and development, the R&D Valley of 
Death.  Funding will be available to assist companies with promising and novel 
therapeutics and diagnostics in both preclinical and clinical stages. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Unspecified Location 
Small businesses are major drivers of innovation. Facile, motivated, numerous, and 
creative, these small businesses can extend the limits of R&D in a way large 
companies with secure product lines are unable to do. However, small businesses 
often encounter difficulty securing capital in the so called, Valley of Death the 
period between a research idea with possible application to the time the safety and 
efficacy of a product is demonstrated in human clinical trials … Common end-
pathways within the Valley of Death include development of pharmacological 
assays, scale-up of production from lab-scale to clinical-trials scale, development of 
suitable formulations, evaluation of chemical stability, evaluation of materials 
testing for durability or reactivity, undertaking initial toxicology studies, and 
planning and implementation of clinical trials. 
Occurrences of ‘Valley of Death’: 2 (1 repetition) 
Coding: Funding gap, Location Described 
Key components of the translational research process include research 
prioritization, an expert workforce, multidisciplinary collaborative work, facilitated 
information exchange, strategic risk taking, support of small innovative businesses 
caught along common pathways in the research and development Valley of Death, 




private entities early on in the translational research endeavor that are skilled in the 
manufacturing and marketing process. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Development gap, Unspecified Location 
 
CONGRESSIONAL RECORD—SENATE February 15, 2006 
I want to point out a few things that we have proposed to make sure that small 
businesses are successful in innovating, and one is we have a constellation of 
proposals that will help small businesses across what is called the valley of death 
which is where they cannot get financing when they have a good idea but cannot 
quite get to commercialization. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—SENATE May 4, 2006 
The fourth major area that my bill addresses is innovation at the small business 
level. Recently, representatives of a number of small nanotechnology companies 
came to visit me. They told me that their greatest problem was surviving what they 
called the ‘‘valley of death.’’ That’s what they called the first few years of business, 
when an entrepreneur has a promising technology but little money to test or develop 
it. Many businesses simply do not survive the ‘‘valley of death.’’ I believe that 
Congress should find a way to assist these businesses with promising technology. 
Occurrences of ‘Valley of Death’: 2 (1 repetitions) 
Coding: Funding gap, Unspecified Location 
 
CONGRESSIONAL RECORD—HOUSE September 26, 2006 
While the law set aside $5.6 billion over 10 years to obtain drugs for the Strategic 
National Stockpile, companies receive very little compensation until they can 
deliver a minimum number of doses. As a result, many of these potential drugs 
languish in the laboratory in what is known as the ‘‘Valley of Death.’’ As with any 
drug, the development of biodefense drugs require efficacy trials, toxicity testing, 
production design and a range of other activities that are expensive but necessary to 
determine whether a drug will work, whether it is safe and how it will be 
manufactured. The centerpiece of this legislation that we are on the floor on behalf 
of this evening develops a new, or places a new office within HHS, the Biomedical 
Advanced Research and Development Authority, BARDA, which would be a single 
point of Federal authority for the development of medical countermeasures. This 




stages of their work, helping to reduce financial risks of taking on this great 
challenge. In other words, we are going to get the job done. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
So we came up with the single point of authority to make quick decisions; and the 
Valley of Death takes a long time, 8 to 12 years, to develop these vaccines, very 
labor intensive, a lot of intellectual power applied to coming up with the right 
vaccine to be the right prophylactic for what we know is a bioterrorism or natural-
occurring event. That Valley of Death, because we are the single source of those 
contracts, was very real and stalling what we know is great research to happen for 
the cure and the development of these vaccines. Also, we found that it did not 
motivate academic researchers, drug and vaccine manufacturers and other possible 
partners to commit substantial resources. 
Occurrences of ‘Valley of Death’: 2 (1 repetitions) 
Coding: Development gap, Unspecified location 
CONGRESSIONAL RECORD—Extensions of Remarks December 27, 2006 
This legislation will enable the government to better develop, procure, and make 
available countermeasures to chemical, biological, radiological and nuclear agents 
for use in a public health emergency. Bioterror countermeasures for agents of 
terrorism have no market other than the government. This legislation will provide 
assurance to companies that the government is fully engaged and a willing and able 
business partner. This legislation will speed up the development and procurement 
process by reorganizing and enhancing these responsibilities into the Biomedical 
Advanced Research and Development Agency, BARDA. 1. BARDA would create a 
single point of authority within government. 2. BARDA would streamline the 
approval and acquisition process to help bridge the ‘‘valley of death’’ for bio-
pharmaceutical research. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Unspecified cause, Unspecified location 
 
CONGRESSIONAL RECORD—SENATE January 4, 2007 
The fourth major area that my bill addresses is innovation at the small business 
level. Last year, representatives of a number of small nanotechnology companies 
came to visit me. They told me that their greatest problem was surviving what they 
called the valley of death. That’s what they called the first few years of business, 
when an entrepreneur has a promising technology but little money to test or develop 
it. Many businesses simply do not survive the valley of death. 
Occurrences of ‘Valley of Death’: 2 (1 repetitions) 





CONGRESSIONAL RECORD—SENATE January 17, 2007 
What we are talking about here is start-up capital for many of these businesses. We 
are not talking necessarily the United States taxpayer funding these things 
indefinitely ...That is a good investment for the country, if we choose wisely. But 
these companies will tell you they have to cross the valley of death, to get from 
development, where they have their prototype, until they can really commercialize 
it. And that is where Uncle Sam can happen. And we will get a lot more bang for 
our buck helping a battery company that will help us drive plug-in hybrids a few 
years from now than we will just giving it to a company that made $22 billion last 
year in the oil and gas markets 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—HOUSE May 3, 2007 
One of the biggest stumbling blocks to innovation is the technology so called 
Valley of Death the gap between angel funding and measurable venture capital, the 
lack of adequate private venture capital for early stage, high-risk, high-reward 
technology development … Today, the Valley of Death remains, but the global 
innovative environment has changed. H.R. 1868 responds to this by replacing ATP 
with the Technology Innovation Program, or TIP, which would provide limited, 
cost-shared grants to small and medium size firms and joint venture to pursue high 
risk, high-reward technologies, with potential for broad public benefit. 
Occurrences of ‘Valley of Death’: 2 (1 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—HOUSE August 2, 2007 
TIP will help small, high-tech firms with big ideas cross the technologic valley of 
death by providing them with limited cost-shared funding to develop technologies 
that address critical national needs either alone or in joint ventures. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Unspecified location 
 
CONGRESSIONAL RECORD—Extensions of Remarks August 2, 2007  
Incubational research refers to early, cutting-edge research that often occurs shortly 
after university laboratory research and prior to large-scale clinical trials. This stage 




results in promising investigational therapies and products withering on the vine for 
lack of adequate capital. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—HOUSE September 27, 2007 
Venture capital not only serves as the raw material for economic growth and job 
creation, but also acts as fuel for the pursuit of new ideas and innovation. Without 
it, businesses cannot expand, and even the best ideas wither and die in what has 
come to be known as the Valley of Death between setup and commercialization. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—SENATE April 30, 2008 
From Ralph Dahl’s farm in northwest Montgomery County and the technology he 
has employed, to high-tech companies in Cleveland looking for financing but 
fearing the so-called valley of death, to eager entrepreneurs in Athens who are 
installing solar panels and wind turbines all over their part of the State, to the work 
of Stark State on fuel cells. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Unspecified location 
 
CONGRESSIONAL RECORD—SENATE May 7, 2008 
Lastly, the Accelerating Cures Act of 2008 uniquely adds resources to guide 
researchers through the Valley of Death, a stage in biomedical development 
between research and commercialization where the success of an initiative is 
dependent on feasibility and profitability that can only be established by a market 
that, by definition, has not yet developed. With the bill’s strengthening and 
broadening of the Small Business Innovation Research and Small Business 
Technology Transfer programs and making available resources such as the Rapid 
Access to Intervention Development and Translational Development programs, 
investigators, institutions, small businesses, and other entities, will be better suited 
to navigate the regulatory and commercialization processes. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Development gap, Location Described 
Key components of the translational research process include research 




multidisciplinary collaborative work, strategic risk taking, support of small 
innovative businesses caught along common pathways in the research and 
development Valley of Death, simplification and promotion of the clinical research 
endeavor, and early involvement of private entities that are skilled in the 
manufacturing and marketing process in the translational research endeavor … The 
Valley of Death is a stage in biomedical development between research and 
commercialization where the success of a product is dependent on its profitability. 
(b) PURPOSE.—The purpose of this Act is to create a new pathway to curing 
disease by enhancing public and private research to translate new discoveries from 
bench to bedside. 
Occurrences of ‘Valley of Death’: 2 (1 repetitions) 
Coding: Development gap, Location Described 
 
CONGRESSIONAL RECORD—SENATE July 8, 2008 
The missing ingredient that this bill seeks to supply concerns traversing the so-
called valley of death. This is the part of the development cycle of a new 
technology when the technology has been demonstrated at a lab or pilot scale and is 
ready to be demonstrated at a commercial scale. It is here, we are told, where new 
technologies, and particularly capital-intensive energy technologies, often languish 
for want of funding. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—SENATE April 28, 2009 
While the NIH funds much of the basic biomedical research at universities across 
the country, the CAN would take those findings found through basic research and 
provide funding to fill the gap between laboratory discoveries and life-saving 
medical therapies. This funding gap—often referred to as the valley of death arises 
after Federal basic science support ends and before investors are willing to commit 
to a promising discovery. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—HOUSE May 6, 2009 
I hope, and it’s not a done deal yet, but I hope we will be creating a thing called a 
green bank, where Uncle Sam will provide a revolving fund that will provide 
lending for some of these businesses at what is called the valley of death.  A lot of 
these businesses, you get the people in a garage, they come up with a brilliant idea. 




scale it up, but when it comes time to put it in the factory, to the build the first 
factory, they can’t get a loan because banks just won’t loan on sort of the first 
commercial-sized projects.  
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—HOUSE July 8, 2009 
Mrs. BIGGERT.  Mr. Chair, I rise today in strong support of H.R. 2965, a bill to 
reauthorize the Small Business Innovation Research (SBIR) and Small Business 
Technology Transfer Programs (STTR).  Too often, I hear from small businesses in 
my district about what I call the valley of death that period when a firm has 
developed a new technology but faces difficulties commercializing it and moving it 
to the market. In an economy where credit is scarce, the timing to provide stable 
resources for small tech companies is now. There are hundreds of healthcare and 
energy solutions past discovery and development. They only need that one final 
push to advance to the marketplace. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
The second item which I urge for inclusion in comprehensive health reform 
legislation is specified in S. 914, the Cures Acceleration Network Act which I 
introduced on April 28, 2009. That bill would help our nation’s medical research 
community bridge what practitioners call the ‘‘valley of death’’ between 
discoveries in basic science and new effective treatments and cures for the diseases. 
This translational medical research will accelerate medical progress at the patient’s 
bedside and maximize the return on the substantial investments being made on bio-
medical research. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Development gap, Location Described 
There has been identified a so-called ‘‘valley of death’’ between the bench and 
clinical research and the bedside and application of the research. The 
pharmaceutical companies do not take up this issue because of the cost. This is 
something which ought to be taken up by the Federal Government as the dominant 
funder for the National Institutes of Health. So should the comprehensive health 
care include this issue to address, in a meaningful way, the very high costs of 
medical care? Certainly, if the tests make a determination that the less-expensive 
items are the ones which ought to be followed, that could meet the Federal standard 
and that could prevail. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 





CONGRESSIONAL RECORD—SENATE July 13, 2009 
… strengthens the Office of Technology at the SBA so that it has the authority and 
resources to carry out its duty to oversee the SBIR and STTR programs across the 
government; streamlines and improves data collection and reporting requirements 
for the SBIR and STTR programs, including developing metrics for annual 
evaluations by each participating agency, as reflected in the amendment by Dr. 
COBURN; helps SBIR and STTR companies move their technologies across the 
‘‘valley of death’’ between the lab and the marketplace and into products and 
technologies for the agencies; and addresses ‘‘jumbo’’ awards, those awards that 
have greatly exceeded the $100,000 and $750,000 guidelines for Phase I and Phase 
II and cut out other businesses. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—HOUSE September 16, 2009 
 
As we face new technologies, be they hybrid, be they new fuel sources like second-
generation ethanol or hydrogen, those technologies as they mature across a pilot 
production line will ultimately produce a vehicle that will be offered to the American 
people. The business model of going from the laboratory to the actual showroom 
floor is as complex as the research and development. This amendment seeks to 
recognize that and lower those barriers. Visualize, if I might offer this: as the vehicle 
rolls out of the laboratory, and we have all raised children, I have a teenager. I know 
how to get that teenager through college. And by golly, that is what this concept 
does. It helps that vehicle stand on its own so it can be proudly purchased by 
Americans. Mrs. BIGGERT. Reclaiming my time, I know you are talking about the 
commercialization, which is what we sometimes call the ‘‘valley of death’’ for 
companies to get out beyond the demonstration to the marketplace which is probably 
the hardest for so many companies. And you think that this will help a lot of 
different companies be able to do that? 
 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Development gap, Location Described 
CONGRESSIONAL RECORD—HOUSE October 20, 2009 
We need to go from research that is done at our universities and the private sector 
and further deploy into the commercialization zone, into the manufacturing efforts, 
those ideas. We have failed after that research investment. We need to have that 
valley of death as it is termed, where we don’t get the seed money that is necessary 
for a lot of this innovative spark to take its presence in our American economy. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 




And only one phenomenon stands in the way of our accomplishing our national 
goals through the automobile industry, the phenomenon known as, and may I quote 
the automobile industry, ‘‘the valley of death.’’  … The valley of death is an 
automotive industry reference to the treacherous territory between proven feasibility 
in the research laboratory and the commercially successful products in the 
marketplace. Every single new technology that we have come to enjoy in 
automobiles, from power brakes and power steering to factory air, has languished in 
the valley of death until it became a commercially available product in the mass 
market …The least difficult of these technologies is the refinements to existing 
conventional engine technology, already discussed, and the most difficult are the 
advanced technologies that are brand new to the marketplace. Automakers 
everywhere recognize that the technologies at the difficult are the ones that cannot 
cross this automotive valley of death alone. Successful movement from research 
and development successes to market successes require the cooperation and support 
of national governments. 
Occurrences of ‘Valley of Death’: 4 (3 repetitions) 
Coding: Development gap, Location Described 
As it appeared in Fortune magazine, I quote, ‘‘The valley of death is auto industry 
speak. It is a metaphorical desert where emerging technologies reside while car 
executives figure out which of the experiments ought to make their way into actual 
cars. Every automotive leap forward has done time in the valley, turbo chargers, 
fuel injections, even gasoline electric hybrids like Toyota’s Prius. Hydrogen fuel 
cell vehicles, the alternative energy flavor of the month back in 2003, are the ones 
languishing today, along with hovercraft and other assorted concept cars, but 
perhaps not for much longer. A number of automakers are now renewing their push 
for hydrogen, and now it is looking as though hydrogen cars will make its way out 
of this conceptual vehicular valley of death. 
Occurrences of ‘Valley of Death’: 3 (2 repetitions) 
Coding: Development gap, Location Described 
 
CONGRESSIONAL RECORD—SENATE October 30, 2009 
We have set up an innovative new financing mechanism, the Sustainable Energy 
Utility, that will help get clean technologies through the so-called valley of death 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Unspecified location 
 
CONGRESSIONAL RECORD—HOUSE November 18, 2009 
 
This is all about growing jobs. We hear it all across America. People are looking for 
jobs. This is a good way to develop those jobs—R&D jobs, manufacturing jobs. 




Federal resources to be matched with the angel network and the venture capitalists 
that take the idea from the lab, from the investment, from both the private sector, 
academia, or maybe even government, taking that and transitioning it over into the 
commercial sector, into the manufacturing sector—that is the resource we need. 
 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—HOUSE December 15, 2009 
We have not provided for that funding mechanism to take the whiz-kid ideas in the 
lab and in the R&D centers— both public and private and at academia. We have not 
provided the funding to deploy those into manufacturing or into retail use so that we 
can get the return on investment that was made. The Angel Network, the venture 
capitalists—that ‘‘valley of death’’ as it is labeled—needs to be addressed. If we do 
that, we are providing more jobs, not just in R&D, but by inducing wiser 
manufacturing operations. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—SENATE March 19, 2010 
We have people coming in all the time wanting to get through what is called the 
valley of death, if they have a new idea. A new idea needs to get sustained funding 
and support in order to demonstrate at scale. Often it is hard to get the money. That 
is part of the problem in terms of the valley of death that they have to go through. 
Some of them never make it through. There is a person who is developing synthetic 
microbes that can be used to consume, or in layman’s terms, eat the coal and leave 
methane in its wake. Wouldn’t that be interesting: synthetic microbes that would 
turn a coal seam into methane. 
Occurrences of ‘Valley of Death’: 2 (1 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—HOUSE May 12, 2010 
Too often, I hear from small businesses in my district about what I call the valley of 
death that period when a firm has developed a new technology but faces difficulty 
commercializing it and moving it into the market. By facilitating commercialization 
and opening access to advanced Federal facilities, this bill removes those hurdles.  
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 




Unlike research in biotech and defense, technology developed through energy R&D 
must break into a deeply entrenched market at a competitive cost in order to be 
successful. We need policies that can help overcome the valley of death where great 
ideas frequently stall before they have reached the critical proof-of-concept stage. 
That’s what we do in this amendment. We have worked with business, universities, 
and venture capital groups in developing this legislation. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
The IPO market is where small and medium-size businesses go to get the capital 
they need to grow, to pass through the valley of death, to get on with what they 
have to do. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Unspecified location 
 
CONGRESSIONAL RECORD—HOUSE December 21, 2010 
 
Secondly, with regard to the research, it is fundamental. I come from California, the 
great Silicon Valley and all of those new technologies come from the research at the 
universities in the surrounding area. This legislation promotes that research agenda 
across the Nation, not just in California, but at every other research institution 
throughout the United States. And finally, there is a major piece of this legislation 
that talks about making it in America. If we are going to have a strong middle class, 
a strong economy, we must once again make it in America. This legislation provides 
some fundamental elements necessary for us to do that. For example, the loan 
guarantee that was degraded just a few moments ago is exceedingly important 
because that’s the valley of death. How does an entrepreneur, how does a new 
business get through the valley of death? 
 
Occurrences of ‘Valley of Death’: 2 (1 repetitions) 
Coding: Funding gap, Unspecified location 
CONGRESSIONAL RECORD—SENATE February 2, 2011 
All of these companies started with angel investment to get them through what they 
call the valley of death. The valley of death is usually that period where something 
has gone from the idea stage to the marketplace. They usually need somewhere 
between $1 million and $4 million to get their ideas to market. Our bill is designed 
to bridge that gap and cross that valley of death so we can see a lot of startup 
companies come into the marketplace. 
Occurrences of ‘Valley of Death’: 3 (2 repetitions) 





CONGRESSIONAL RECORD—HOUSE March 15, 2011 
Now, not every company will turn into Qualcomm. But without programs like this, 
there is what they call a valley of death. There are ideas that are created out of the 
minds and hearts of Americans who have been well educated, raised to believe that 
dreams come true, and are encouraged to risk. We are natural risk takers. We have 
these ideas and these innovations. But what happens is, if there is not that 
important, early funding to develop that kind of science and technology, in large 
measure some of these ideas just fall into the valley of death. 
Occurrences of ‘Valley of Death’: 2 (1 repetitions) 
Coding: Funding gap, Location Described 
 
Then we can continue to be the leaders in cutting- edge innovation, and the Federal 
Government can do its part—an important part—that venture capitalists can’t do, big 
banks don’t want to do, investment bankers aren’t made to do, and small community 
banks don’t do in this kind of lending. Only patient, directed capital can give that 
boost over the valley of death and create that bridge so small businesses and our 
scientists and engineers can walk over it safely. 
 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Unspecified location 
That is what this program does— incentivizes or gives grants or contracts to 
emerging technologies well before a bank would take a look, well before a venture 
capital fund would even look in their direction. You have to develop the technology 
to a point and then have it launched. This is where there is what he described as the 
valley of death—great ideas, but there is just not a lot of venture capital out there 
and particularly in this recessionary period. So he says we helped, that without this 
program, it would have been very difficult to grow their company. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—Extensions of Remarks May 27, 2011 
These improvements to national security parallel new economic opportunities for 
the biofuel industry. According to the Biotechnology Industry Association, 
‘‘Section 526 is helping low carbon fuels bridge the ‘valley of death’ between 
development and commercialization,’’ and is ‘‘already helping the Air Force and 
Navy meet its alternative fuel goals.’’ The domestic biofuels industry contributes 
400,000 jobs and $53 billion to the American economy while supporting 
deployment of domestically-produced biofuels for our Armed Forces. 




Coding: Development gap, Location Described 
 
CONGRESSIONAL RECORD—HOUSE July 14, 2011 
The Department of Energy spends millions of dollars each year on research and 
development for new technologies. However, that R&D often reaches a point 
known as the Valley of Death. The Valley of Death is where promising new 
technologies fade into obscurity because they can’t attract the capital investments to 
move from concept to commercialization. In essence, on one side of the Valley of 
Death is research and development; good ideas. On the other side is the actual 
deployment and commercialization. A demonstration project takes the research and 
development just a little bit further and bridges this divide so that private entities 
will be interested in deployment, private entities will be interested in 
commercialization. This good use of federally funded demonstration projects is 
critical to reducing the risk to private sector investors and allows technologies to 
cross the Valley of Death and establish commercial viability for investors and, 
indeed, attract their interest. 
Occurrences of ‘Valley of Death’: 4 (3 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—HOUSE December 6, 2011 
BARDA, which helped bridge what many termed the valley of death that had 
prevented many countermeasure developers from being successful. BARDA was 
created because we recognize that most of the CBRN countermeasures do not yet 
exist and medical development countermeasure is a risky, expensive and lengthy 
process. BARDA bridges the funding gap between early-stage research and the 
ultimate procurement of products from the SRF fund from the national stockpile. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Location Described 
CONGRESSIONAL RECORD—SENATE June 14, 2012 
There is so much. I could spend a long time going through all of the exciting efforts 
going on, literally from the east coast to the west coast, North and South, where 
creative entrepreneurs are coming forward, with support from the USDA to be able 
to get them through what is often called the valley of death, as they have a great 
idea but are trying to get it to commercialization, and efforts that are leveraging 
private dollars and public dollars to be able to have these companies move forward 
into full commercialization. Then they can create jobs, create renewable energy, get 
us off of foreign oil or create other kinds of products—all kinds of opportunities for 
us around products. That leads me to another important piece, which is R&D, which 
is always a very important part of what needs to be done as we are looking at these 




fact, most of them start as small businesses with a great idea, and they are looking 
for how to turn that into a great business, and hiring people, and so on. The Biomass 
Research and Development Initiative is an integral component to bridging the gap 
between technology development and commercialization. As I said, this is often 
called the valley of death. If you are somebody out there who is an entrepreneur 
with a great idea, how do you actually convince somebody to invest in it so you can 
move forward?  
Occurrences of ‘Valley of Death’: 2 (1 repetitions) 
Coding: Funding gap, Location Described 
 
CONGRESSIONAL RECORD—HOUSE May 15, 2013 
As you are well aware, one of the barriers to start-up company growth is access to 
capital. Although the Reg A offerings are supposed to help emerging companies get 
access capital, the cost of compliance with regulatory burdens made the $5 million 
cap unworkable. Congress was absolutely right to pass the JOBS Act requiring the 
SEC to promulgate rules to raise the cap to $50 million. Doing so will open new 
pathways by which startups and emerging companies, including those stuck in the 
proverbial ‘‘valley of death,’’ can access capital, allowing them to grow and create 
new jobs. But more than a year after this bipartisan triumph for innovators, the SEC 
hasn’t even published Reg A rules. H.R. 701 will fix this and is urgently needed. 
There is much talk in Washington about helping start-ups, but your bill takes  
tangible action toward achieving that goal and ensuring the promise of the JOBS 
Act is realized.  We commend you for finding a bi-partisan solution that will have 
real-world benefits for America’s entrepreneurs and innovators. CONNECT stands 
ready to assist you as the bill advances in the House and strongly encourages 
Majority Leader Reid to promptly place the bill on the Senate floor calendar. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 
Coding: Funding gap, Unspecified location 
 
CONGRESSIONAL RECORD—SENATE October 31, 2013 
My bill would fertilize America’s innovation ecosystems so that scientific 
breakthroughs can more effectively navigate the so-called valley of death between 
the lab and the factory and reach their commercial potential. America’s universities 
and research institutions are truly national treasures, and our venture capitalists and 
entrepreneurs are the sharpest in the world. When we sprinkle the right mix of 
scientific brainpower and capitalist drive, we get something uniquely American and 
extremely potent in terms of its economic impact. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 





CONGRESSIONAL RECORD—SENATE November 13, 2013 
In those sectors, we need to look at ways of partnering with our innovators on 
proof-of-concept and demonstration projects so that more breakthroughs can bridge 
the so-called Valley of Death between the lab bench and commercialization of a 
new technology. 
Occurrences of ‘Valley of Death’: 1 (0 repetitions) 







CODING RESULTS FOR THE DIMENSIONS OF A FUNDING SHORTFALL 
DRAWN FROM CITATIONS OF THE VALLEY OF DEATH CONTAINED TO 

































































































3/7/2001         
7/20/2001 1 1 4  3   1 
9/10/2001 4 1 1     1 
9/24/2001     2   2 
2/25/2004 3  2 2    4 
6/9/2005         
7/29/2005 2  2   1  2 
9/14/2005 (1) 1  2 2 1   1 
9/14/2005 (2)   1     1 
10/21/2005         
12/14/2005 (1) 1       1 
12/14/2005 (2) 2       1 
12/14/2005 (3)   1     2 
12/14/2005 (4)         
2/15/2006  1      1 
5/4/2006    1    2 
9/26/2006 (1)  1      1 
9/26/2006 (2)         
12/27/2006         
1/4/2007    1    2 
1/17/2007 1  1  1   1 
5/3/2007 1  2   1  2 
8/2/2007 (1) 1       1 
8/2/2007 (2)   1  1   1 
9/27/2007   1     1 



































































































5/7/2008 (1)         
5/7/2008 (2)         
7/8/2008 1  1     1 
4/28/2009 3       1 
5/6/2009 1  1   2  1 
7/8/2009 (1)      1  1 
7/8/2009 (2)         
7/8/2009 (3) 1       1 
7/13/2009      1  1 
9/16/2009         
10/20/2009 (1)    1 1   1 
10/20/2009 (2)         
10/20/2009 (3)         
10/30/2009  1      1 
11/18/2009   1  1   1 
12/15/2009 2  1  1   1 
3/19/2010 1   1    2 
5/12/2010 (1)         
5/12/2010 (2)   1     1 
5/12/2010 (3)   1     1 
12/21/2010      1  2 
2/2/2011     1   3 
3/15/2011 (1) 1       2 
3/15/2011 (2)   2  1   1 
3/15/2011 (3) 1  2   1  1 
5/27/2011         
7/14/2011 1  1  1   4 
12/6/2011 2       1 
6/14/2012     1   2 
5/15/2013   3     1 
10/31/2013   2     1 






CODING RESULTS FOR THE DIMENSIONS FOR LOCATION PARAMETERS 
DRAWN FROM CITATIONS OF THE VALLEY OF DEATH CONTAINED TO 






























































































3/7/2001   1 1    1 
7/20/2001 2  2 1 3 1  1 
9/10/2001         
9/24/2001  2 1 1 3 1  2 
2/25/2004 1 1  6 2 5  4 
6/9/2005   1     1 
7/29/2005   1  1   2 
9/14/2005 (1) 2   1 3 1  1 
9/14/2005 (2) 1  1  2   1 
10/21/2005 2   1    2 
12/14/2005 (1)    2    1 
12/14/2005 (2)         
12/14/2005 (3)   1 1    2 
12/14/2005 (4)         
2/15/2006 1  1     1 
5/4/2006         
9/26/2006 (1)    1    1 
9/26/2006 (2)         
12/27/2006         
1/4/2007         
1/17/2007 1       1 
5/3/2007     1   2 
8/2/2007 (1)         
8/2/2007 (2)   1 1    1 
9/27/2007 1  2 1 1   1 
































































































5/7/2008 (1) 2    2 1  1 
5/7/2008 (2) 1   1 1   2 
7/8/2008 1     2  1 
4/28/2009     1   1 
5/6/2009   1     1 
7/8/2009 (1) 2     2  1 
7/8/2009 (2)     1   1 
7/8/2009 (3)     1   1 
7/13/2009    1 1 1  1 
9/16/2009 1     1  1 
10/20/2009 (1) 1  1     1 
10/20/2009 (2) 2   1 1 4  4 
10/20/2009 (3)    1    3 
10/30/2009         
11/18/2009 1  1     1 
12/15/2009   1     1 
3/19/2010   2     2 
5/12/2010 (1) 2     1  1 
5/12/2010 (2)   1   1  1 
5/12/2010 (3)         
12/21/2010         
2/2/2011   2  1   3 
3/15/2011 (1)   3     2 
3/15/2011 (2)         
3/15/2011 (3)   1     1 
5/27/2011 1    2   1 
7/14/2011 4  1  1   4 
12/6/2011    1 3   1 
6/14/2012 3  4 2 1   2 
5/15/2013         
10/31/2013 1    1   1 
11/13/2013 1    2   1 
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